| 1 | P 140 | - | - | - | - | [1] 49 49 💬
|
| 2 | P-1037 | - | - | - | - | [1] 299 299 💬
|
| 3 | P-188 NF | - | - | - | - | [1] 113 113 💬
|
| 4 | P-552 | - | - | - | - | [1] 53 53 💬
|
| 5 | P-CD19CD20-ALLO1 Cells | - | - | - | - | [2] 13 13, 49 💬
|
| 6 | P144 | - | - | - | - | [1] 51 51 💬
|
| 7 | P144 cream | - | - | - | - | [1] 51 51 💬
|
| 8 | P144 Cytokine Inhibitor | - | - | - | - | [1] 51 51 💬
|
| 9 | P144 Cytokines Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 10 | P144 DIGNA CREAM | - | - | - | - | [1] 51 51 💬
|
| 11 | P144. Cytokines Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 12 | P28GST | - | - | - | - | [1] 96 96 💬
|
| 13 | P2B001 | - | - | - | - | [1] 6 6 💬
|
| 14 | P2B001 0.6/0.75 mg | - | - | - | - | [1] 6 6 💬
|
| 15 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [5] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Rasagiline mesylate
,
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬
| [19] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 16 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [5] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Rasagiline mesylate
,
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬
| [19] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 17 | P32/98 | - | - | - | - | [1] 37 37 💬
|
| 18 | P32/98 3% | - | - | - | - | [1] 37 37 💬
|
| 19 | P38 (4) Map Kinase Inhibitor | - | - | - | - | [1] 46 46 💬
|
| 20 | P38 Inhibitor (4) | - | - | - | - | [1] 46 46 💬
|
| 21 | P38 Inhibitor (4) 150mg | - | - | - | - | [1] 46 46 💬
|
| 22 | P38 Inhibitor (4) 25mg | - | - | - | - | [1] 46 46 💬
|
| 23 | P38 Inhibitor (4) 300mg | - | - | - | - | [1] 46 46 💬
|
| 24 | P38 Inhibitor (4) 50mg | - | - | - | - | [1] 46 46 💬
|
| 25 | P38 Inhibitor (4) 75mg | - | - | - | - | [1] 46 46 💬
|
| 26 | P38 Map Kinase Inhibitor | - | - | - | - | [1] 46 46 💬
|
| 27 | P38(4) Map Kinase Inhibitor | - | - | - | - | [1] 46 46 💬
|
| 28 | PA101 | - | - | - | - | [1] 85 85 💬
|
| 29 | PAAG15 | - | - | - | - | [1] 299 299 💬
|
| 30 | Pabinafusp alfa | [1] Pabinafusp alfa Pabinafusp alfa | [1] Pabinafusp alfa
Pabinafusp alfa
💬
| [2] IDS IDS, TFRC 💬
| [8] Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome biogenesis, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 19 19 💬
|
| 31 | Paclitaxel | [1] Paclitaxel Paclitaxel | [1] Paclitaxel
Paclitaxel
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [2] 46 46, 85 💬
|
| 32 | Pacritinib | [1] Pacritinib Pacritinib | [1] Pacritinib
Pacritinib
💬
| [2] FLT3 FLT3, JAK2 💬
| [31] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Efferocytosis, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Necroptosis, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Prolactin signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis 💬 | [1] 331 331 💬
|
| 33 | Pactimibe | [1] Pactimibe Pactimibe | - | - | - | [1] 79 79 💬
|
| 34 | Pactimibe sulfate | [1] Pactimibe Pactimibe | - | - | - | [1] 79 79 💬
|
| 35 | PADN | - | - | - | - | [1] 86 86 💬
|
| 36 | Padsevonil | [1] Padsevonil Padsevonil | [1] Padsevonil
Padsevonil
💬
| [3] SV2A SV2A, SV2B, SV2C 💬
| [1] ECM-receptor interaction ECM-receptor interaction 💬 | [1] 149 149 💬
|
| 37 | PAH background therapy | - | - | - | - | [1] 86 86 💬
|
| 38 | PAH medication | - | - | - | - | [1] 86 86 💬
|
| 39 | PALG/ rATG | - | - | - | - | [1] 60 60 💬
|
| 40 | PALI-2108 | - | - | - | - | [2] 96 96, 97 💬
|
| 41 | Palifermin | [1] Palifermin Palifermin | [1] Palifermin
Palifermin
💬
| [1] FGFR2 FGFR2 💬
| [12] Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | [6] 13 13, 36, 38, 39, 65, 96 💬
|
| 42 | Paliperidone | [1] Paliperidone Paliperidone | [2] Paliperidone
Paliperidone
,
Paliperidone palmitate
💬
| [2] DRD2 DRD2, HTR2A 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 43 | Palmitoleic Acid | [1] Palmitoleic Acid Palmitoleic Acid | - | - | - | [2] 96 96, 97 💬
|
| 44 | Palmitoleic Acid + Infliximab | [2] Infliximab Infliximab, Palmitoleic Acid | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 45 | Palmitoylethanolamide (PEA) | - | - | - | - | [1] 97 97 💬
|
| 46 | Palopegteriparatide | [1] Palopegteriparatide Palopegteriparatide | [1] Palopegteriparatide
Palopegteriparatide
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 47 | Palopegteriparatide (TransCon PTH) | [1] Palopegteriparatide Palopegteriparatide | [1] Palopegteriparatide
Palopegteriparatide
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 48 | PALOVAROTENE | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 49 | PALOVAROTENE - 1.5mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 50 | PALOVAROTENE - 10 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 51 | PALOVAROTENE - 1mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 52 | PALOVAROTENE - 2 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 53 | PALOVAROTENE - 2.5 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 54 | PALOVAROTENE - 3 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 55 | PALOVAROTENE - 4 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 56 | PALOVAROTENE - 5 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 57 | PALOVAROTENE 1.5 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 58 | Palovarotene dose level 1 | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 59 | Palovarotene dose level 2 | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 60 | Palovarotene dose level 3 | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 61 | Palovarotene dose level 4 | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 62 | PALOVAROTENE-2 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 63 | PALOVAROTENE-3 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 64 | PALOVAROTENE-4 mg | [1] Palovarotene Palovarotene | [1] Palovarotene
Palovarotene
💬
| - | - | [1] 272 272 💬
|
| 65 | Paltusotine | [1] Paltusotine Paltusotine | [2] Paltusotine
Paltusotine
,
Paltusotine hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 66 | Paltusotine (Free base) | [1] Paltusotine Paltusotine | [2] Paltusotine
Paltusotine
,
Paltusotine hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 67 | PaltusotineProduct Code: CRN00808Pharmaceutical Form: TabletINN or Proposed INN: Paltusotine (Free base)CAS Number: 2172870-89-0Current Sponsor code: CRN00808Other descriptive name: PaltusotineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use | [1] Paltusotine Paltusotine | [2] Paltusotine
Paltusotine
,
Paltusotine hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 68 | Palynziq | - | - | - | - | [1] 240 240 💬
|
| 69 | Palynziq® | - | - | - | - | [1] 240 240 💬
|
| 70 | Pamidronate | - | - | - | - | [3] 270 270, 271, 274 💬
|
| 71 | Pamidronate (Aredia) | - | - | - | - | [1] 274 274 💬
|
| 72 | Pamidronate Disodium | [1] Pamidronic acid Pamidronic acid | [2] Pamidronate disodium
Pamidronate disodium
,
Pamidronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [1] 274 274 💬
|
| 73 | PAMREVLUMAB | [1] Pamrevlumab Pamrevlumab | [1] Pamrevlumab
Pamrevlumab
💬
| [1] CCN2 CCN2 💬
| [2] Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | [2] 85 85, 113 💬
|
| 74 | Pancreas Powder | - | - | - | - | [1] 299 299 💬
|
| 75 | PANCREASE MT | - | - | - | - | [1] 299 299 💬
|
| 76 | Pancrease MT 10.5, or MT 21 | - | - | - | - | [1] 299 299 💬
|
| 77 | PANCREASLIPASE | - | - | - | - | [1] 299 299 💬
|
| 78 | Pancreatic enzyme (Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose , Metformin, Glimepirde Tablets, Insulin) | [2] Acarbose Acarbose, Metformin | [3] Acarbose
Acarbose
,
Metformin hydrochloride
,
Metformin
💬
| [7] AMY2A AMY2A, AMY2B, GAA, GANC, MGAM, PRKAA1, PRKAA2 💬
| [26] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Carbohydrate digestion and absorption, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Galactose metabolism, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 298 298 💬
|
| 79 | Pancreatic Enzyme Replacement Therapy | - | - | - | - | [1] 298 298 💬
|
| 80 | Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets) | [1] Acarbose Acarbose | [1] Acarbose
Acarbose
💬
| [5] AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬
| [6] Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome biogenesis, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | [1] 298 298 💬
|
| 81 | Pancreatic enzymes | - | - | - | - | [1] 298 298 💬
|
| 82 | Pancreatin | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [2] 298 298, 299 💬
|
| 83 | PANCREATIN (PAncreas Powder) | - | - | - | - | [1] 299 299 💬
|
| 84 | PANCREATINA | - | - | - | - | [1] 299 299 💬
|
| 85 | PANCREATINA (Páncreas Polvo | - | - | - | - | [1] 299 299 💬
|
| 86 | PANCREATINA (Páncreas Polvo) | - | - | - | - | [1] 299 299 💬
|
| 87 | PANCREAZE | - | - | - | - | [1] 299 299 💬
|
| 88 | PANCREAZE® | - | - | - | - | [1] 299 299 💬
|
| 89 | PANCRECARB® (pancrelipase) | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [1] 299 299 💬
|
| 90 | Pancrelipase | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [4] 96 96, 97, 298, 299 💬
|
| 91 | PANCRELIPASE AMYLASE | [2] Pancrelipase Pancrelipase, Pancrelipase amylase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [1] 299 299 💬
|
| 92 | Pancrelipase Delayed Release | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [1] 299 299 💬
|
| 93 | Pancrelipase Delayed Release Capsule | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [2] 298 298, 299 💬
|
| 94 | Pancrelipase Microtablets | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [1] 299 299 💬
|
| 95 | Pancrelipase with bicarbonate | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [1] 299 299 💬
|
| 96 | Pancrelipase/Pancreas Powder | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [2] 298 298, 299 💬
|
| 97 | Pandemrix, | - | - | - | - | [1] 46 46 💬
|
| 98 | Panhematin | - | - | - | - | [1] 254 254 💬
|
| 99 | Pankreatin | - | - | - | - | [1] 299 299 💬
|
| 100 | Pantethine | [1] Pantethine Pantethine | [1] Pantethine
Pantethine
💬
| - | - | [1] 121 121 💬
|
| 101 | Pantoprazole | [1] Pantoprazole Pantoprazole | [2] Pantoprazole sodium
Pantoprazole sodium
,
Pantoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 13 13, 65 💬
|
| 102 | Pantoprazolo 20 mg gastro-resistant tablets | - | - | - | - | [1] 65 65 💬
|
| 103 | PANZYGA | - | - | - | - | [2] 14 14, 63 💬
|
| 104 | Panzytrat | - | - | - | - | [1] 298 298 💬
|
| 105 | Panzytrat 25.000 | - | - | - | - | [1] 298 298 💬
|
| 106 | Panzytrat 25.000 FIP-E units of Lipase | - | - | - | - | [1] 298 298 💬
|
| 107 | PANZYTRAT 25000 | - | - | - | - | [1] 299 299 💬
|
| 108 | Panzytrat® 25,000 | - | - | - | - | [1] 299 299 💬
|
| 109 | Panzytrat® ok | - | - | - | - | [1] 299 299 💬
|
| 110 | Paquinimod | [1] Paquinimod Paquinimod | - | - | - | [2] 49 49, 51 💬
|
| 111 | Paquinimod (ABR-215757) | [1] Paquinimod Paquinimod | - | - | - | [1] 49 49 💬
|
| 112 | PARACETAMOL | - | - | - | - | [6] 3 3, 6, 13, 28, 46, 48 💬
|
| 113 | Paracetamol (acetaminophen) | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 114 | Paracetamol 120Mg/5mL Oral Suspension | - | - | - | - | [1] 3 3 💬
|
| 115 | PARACETAMOLO | - | - | - | - | [10] 2 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
|
| 116 | Paracetamolo 500 mg | - | - | - | - | [1] 13 13 💬
|
| 117 | PARACETAMOLO DC.IT FU | - | - | - | - | [1] 46 46 💬
|
| 118 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | [1] 19 19 💬
|
| 119 | PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE | - | - | - | - | [1] 300 300 💬
|
| 120 | Paracetamolo Zentiva Italia | - | - | - | - | [1] 28 28 💬
|
| 121 | Paraclisib | - | - | - | - | [1] 61 61 💬
|
| 122 | Paraffin oil | - | - | - | - | [1] 291 291 💬
|
| 123 | PARALEN 500 | - | - | - | - | [1] 46 46 💬
|
| 124 | Parapres | - | - | - | - | [1] 6 6 💬
|
| 125 | Parathyroid Allotransplant | - | - | - | - | [1] 235 235 💬
|
| 126 | Parathyroid hormon 1-84 | - | - | - | - | [1] 235 235 💬
|
| 127 | Parathyroid hormone | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [2] 70 70, 235 💬
|
| 128 | Parathyroid Hormone (1-84) Human Recombinant | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 129 | Parathyroid Hormone (rDNA) | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 130 | Parathyroideahormon | - | - | - | - | [1] 235 235 💬
|
| 131 | PARCOPA | - | - | - | - | [1] 6 6 💬
|
| 132 | Pardaprunox | - | - | - | - | [1] 6 6 💬
|
| 133 | Pardoprunox | [1] Pardoprunox Pardoprunox | [2] Pardoprunox hydrochloride
Pardoprunox hydrochloride
,
Pardoprunox
💬
| [3] DRD2 DRD2, DRD3, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 134 | Pardoprunox hydrochloride | [1] Pardoprunox Pardoprunox | [2] Pardoprunox hydrochloride
Pardoprunox hydrochloride
,
Pardoprunox
💬
| [3] DRD2 DRD2, DRD3, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 135 | Parecoxib | [1] Parecoxib Parecoxib | [3] Valdecoxib
Valdecoxib
,
Parecoxib
,
Parecoxib sodium
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [3] 46 46, 71, 271 💬
|
| 136 | Parenteral Remodulin (treprostinil) injection | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 137 | Parenteral Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 138 | PARI eFlow nebulizer system | - | - | - | - | [2] 229 229, 299 💬
|
| 139 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] Paricalcitol
Paricalcitol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 19 19, 66, 218, 238, 298 💬
|
| 140 | PARLODEL | - | - | - | - | [1] 74 74 💬
|
| 141 | Parnaparin | [1] Parnaparin Parnaparin | [1] Parnaparin sodium
Parnaparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 97 97 💬
|
| 142 | PARNAPARIN SODIUM | [1] Parnaparin Parnaparin | [1] Parnaparin sodium
Parnaparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 97 97 💬
|
| 143 | Paroxetine | [1] Paroxetine Paroxetine | [4] Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 6 6, 13, 46, 85 💬
|
| 144 | Paroxetine & Prednisolone | [2] Paroxetine Paroxetine, Prednisolone | [5] Prednisolone
Prednisolone
,
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| [2] NR3C1 NR3C1, SLC6A4 💬
| [4] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 💬
|
| 145 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [5] Prednisolone
Prednisolone
,
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| [2] NR3C1 NR3C1, SLC6A4 💬
| [4] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 💬
|
| 146 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [5] Prednisolone
Prednisolone
,
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| [2] NR3C1 NR3C1, SLC6A4 💬
| [4] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 💬
|
| 147 | Parsaclisib | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [3] 35 35, 53, 61 💬
|
| 148 | Parsaclisib (1 mg) | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 💬
|
| 149 | Parsaclisib (2.5 mg) | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 💬
|
| 150 | Parsaclisinib | - | - | - | - | [1] 61 61 💬
|
| 151 | Part 1 Levulan injection | - | - | - | - | [1] 34 34 💬
|
| 152 | Part 1 Levulan surface application | - | - | - | - | [1] 34 34 💬
|
| 153 | Part 1 Levulan surface application twice | - | - | - | - | [1] 34 34 💬
|
| 154 | Part 1 Levulan surface application twice with microneedling | - | - | - | - | [1] 34 34 💬
|
| 155 | Part 1, JM-010 component Group A | - | - | - | - | [1] 6 6 💬
|
| 156 | Part 1, JM-010 component Group B | - | - | - | - | [1] 6 6 💬
|
| 157 | Part 1, JM-010 component Group C | - | - | - | - | [1] 6 6 💬
|
| 158 | Part 1: LJN452 | - | - | - | - | [1] 93 93 💬
|
| 159 | Part 2, JM-010 combination Group A | - | - | - | - | [1] 6 6 💬
|
| 160 | Part 2, JM-010 combination Group B | - | - | - | - | [1] 6 6 💬
|
| 161 | Part 2, JM-010 component Group C | - | - | - | - | [1] 6 6 💬
|
| 162 | Part 2: LJN452 Dose level 1 | - | - | - | - | [1] 93 93 💬
|
| 163 | Part 2: LJN452 Dose level 2 | - | - | - | - | [1] 93 93 💬
|
| 164 | Part A | - | - | - | - | [1] 46 46 💬
|
| 165 | Part A: 100 mg/mL GSK2618960 | - | - | - | - | [1] 13 13 💬
|
| 166 | Part A: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 167 | Part B | - | - | - | - | [1] 46 46 💬
|
| 168 | Part B Open-Label Extension | - | - | - | - | [1] 51 51 💬
|
| 169 | Part B: Dose of GSK2618960 decided from Part A | - | - | - | - | [1] 13 13 💬
|
| 170 | Part B: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 171 | Part C: Dose of GSK2618960 decided from Part A and B | - | - | - | - | [1] 13 13 💬
|
| 172 | Part C: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 173 | Part D: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 174 | Part I - etoricoxib 60 mg | [1] Etoricoxib Etoricoxib | [1] Etoricoxib
Etoricoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 175 | Part I - etoricoxib 90 mg | [1] Etoricoxib Etoricoxib | [1] Etoricoxib
Etoricoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 176 | Part I- naproxen 1000 mg | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 177 | Part II- etoricoxib 60 mg | [1] Etoricoxib Etoricoxib | [1] Etoricoxib
Etoricoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 178 | Part II- etoricoxib 90 mg | [1] Etoricoxib Etoricoxib | [1] Etoricoxib
Etoricoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 179 | Part II- naproxen 1000 mg | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 180 | Partial Enteral Nutrition | - | - | - | - | [2] 96 96, 271 💬
|
| 181 | Partial enteral nutrition - orally consumed formula | - | - | - | - | [1] 96 96 💬
|
| 182 | Partial resection and sclerotherapy | - | - | - | - | [1] 278 278 💬
|
| 183 | PAS-004 | [1] PAS-004 PAS-004 | - | - | - | [1] 34 34 💬
|
| 184 | PAS-004 Tablets | [1] PAS-004 PAS-004 | - | - | - | [1] 34 34 💬
|
| 185 | PASC transplantation (25 million PASCs/patient) | - | - | - | - | [1] 6 6 💬
|
| 186 | Pasireotida | - | - | - | - | [2] 75 75, 77 💬
|
| 187 | Pasireotida 300 | - | - | - | - | [1] 75 75 💬
|
| 188 | Pasireotida 600 | - | - | - | - | [1] 75 75 💬
|
| 189 | Pasireotida 900 | - | - | - | - | [1] 75 75 💬
|
| 190 | Pasireotide | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 74, 75, 77 💬
|
| 191 | Pasireotide (SOM230), Octreotide (Sandostatin) | [2] Octreotide Octreotide, Pasireotide | [8] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
,
Octreotide hydrochloride
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 192 | Pasireotide 0.3mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 193 | Pasireotide 0.6 MG/ML | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 194 | Pasireotide 0.6mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 195 | Pasireotide 0.9 mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 196 | Pasireotide 20mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 197 | Pasireotide 40mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 198 | Pasireotide 60mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 199 | PASIREOTIDE DIASPARTATE | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 200 | Pasireotide LAR | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 75, 77 💬
|
| 201 | Pasireotide LAR 60 mg | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 202 | Pasireotide long acting release formulation | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 203 | PASIREOTIDE PAMOATE | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 204 | Pasireotide s.c. | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 77 💬
|
| 205 | Pasireotide sub-cutaneous | [1] Pasireotide Pasireotide | [3] Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 206 | Pasireotide with or without cabergoline | [2] Cabergoline Cabergoline, Pasireotide | [4] Cabergoline
Cabergoline
,
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| [6] DRD2 DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬
| [16] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 207 | Pasireotode | - | - | - | - | [1] 75 75 💬
|
| 208 | PAT-001, 0.1% | - | - | - | - | [1] 160 160 💬
|
| 209 | PAT-001, 0.2% | - | - | - | - | [1] 160 160 💬
|
| 210 | Patient Current Care | - | - | - | - | [1] 46 46 💬
|
| 211 | Patient switched from IV vedolizumab to subcutaneous vedolizumab as part of normal patient care | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 212 | Patient treated with DMARD | - | - | - | - | [1] 46 46 💬
|
| 213 | Patients who do not know they are hypertensive but actual blood pressure is high | - | - | - | - | [1] 70 70 💬
|
| 214 | Patients will be randomized to receive EHP-101 | - | - | - | - | [1] 51 51 💬
|
| 215 | Patients with hypertension diagnosis | - | - | - | - | [1] 70 70 💬
|
| 216 | Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses | - | - | - | - | [1] 46 46 💬
|
| 217 | PATISIRAN | [1] Patisiran Patisiran | [2] Patisiran sodium
Patisiran sodium
,
Patisiran
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 218 | Pazopanib | [1] Pazopanib Pazopanib | [1] Pazopanib hydrochloride
Pazopanib hydrochloride
💬
| [6] FLT1 FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
| [33] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 227 227 💬
|
| 219 | PB | - | - | - | - | [2] 67 67, 225 💬
|
| 220 | PB006 | - | - | - | - | [1] 13 13 💬
|
| 221 | PB018 | - | - | - | - | [1] 13 13 💬
|
| 222 | PB1046 | - | - | - | - | [1] 86 86 💬
|
| 223 | PB1046 Injection | - | - | - | - | [1] 113 113 💬
|
| 224 | PB1046 Subcutaneous Injection | - | - | - | - | [1] 86 86 💬
|
| 225 | PB1046, VIP-ELP1-120, Vasomera | [1] Vasomera Vasomera | - | - | - | [1] 86 86 💬
|
| 226 | PBF-509 | - | - | - | - | [1] 6 6 💬
|
| 227 | PBF-677 | - | - | - | - | [1] 97 97 💬
|
| 228 | PBF-999 | - | - | - | - | [1] 8 8 💬
|
| 229 | PBF-999 / 160 mg | - | - | - | - | [1] 8 8 💬
|
| 230 | PBF-999 / 320 mg | - | - | - | - | [1] 8 8 💬
|
| 231 | PBFT02 | [1] PBFT02 PBFT02 | - | - | - | [1] 127 127 💬
|
| 232 | PBGENE-DMD (IV) | - | - | - | - | [1] 113 113 💬
|
| 233 | PBGM01 | [1] PBGM01 PBGM01 | - | - | - | [1] 19 19 💬
|
| 234 | PBI4050 | - | - | - | - | [2] 85 85, 299 💬
|
| 235 | PBKR03 | [1] PBKR03 PBKR03 | - | - | - | [1] 19 19 💬
|
| 236 | PBMC autotransplantation | - | - | - | - | [1] 2 2 💬
|
| 237 | PBT2 | - | - | - | - | [1] 8 8 💬
|
| 238 | PBT434, 5,7-Dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one mesylate | [1] ATH434 ATH434 | - | - | - | [1] 17 17 💬
|
| 239 | PC945 | - | - | - | - | [1] 299 299 💬
|
| 240 | PCA Alone (SOC) | - | - | - | - | [1] 60 60 💬
|
| 241 | PCA plus methadone (Experimental) | [1] Methadone Methadone | [2] Methadone hydrochloride
Methadone hydrochloride
,
Methadone
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, OPRM1 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Estrogen signaling pathway, Glutamatergic synapse, Hormone signaling, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 60 60 💬
|
| 242 | PCO371 | - | - | - | - | [1] 235 235 💬
|
| 243 | PCSK9 Inhibitor [EPC] | - | - | - | - | [1] 79 79 💬
|
| 244 | PCT (PureCell Technologies Complex) | - | - | - | - | [1] 97 97 💬
|
| 245 | PD 0299685 | - | - | - | - | [1] 226 226 💬
|
| 246 | PD 0299685 at 15mg BID | - | - | - | - | [1] 226 226 💬
|
| 247 | PD 0299685 at 30mg BID | - | - | - | - | [1] 226 226 💬
|
| 248 | PD 0360324 | - | - | - | - | [2] 46 46, 84 💬
|
| 249 | PD patients H&Y=1.5-2 Medications OFF | - | - | - | - | [1] 6 6 💬
|
| 250 | PD patients H&Y=1.5-2 Medications ON | - | - | - | - | [1] 6 6 💬
|
| 251 | PD patients H&Y=3 Medications OFF | - | - | - | - | [1] 6 6 💬
|
| 252 | PD patients H&Y=3 Medications ON | - | - | - | - | [1] 6 6 💬
|
| 253 | PD vitamin supplementation | - | - | - | - | [1] 6 6 💬
|
| 254 | PD-0299685 | [1] PD-0299685 PD-0299685 | - | - | - | [1] 226 226 💬
|
| 255 | PD-0325901 | - | - | - | - | [1] 34 34 💬
|
| 256 | PD-RBD | - | - | - | - | [1] 6 6 💬
|
| 257 | PD00377 Na-salt | - | - | - | - | [1] 85 85 💬
|
| 258 | PDA001 | - | - | - | - | [2] 46 46, 96 💬
|
| 259 | PDA001 (cenplacel-L) | [1] Cenplacel-L Cenplacel-L | [1] Cenplacel-L
Cenplacel-L
💬
| - | - | [1] 84 84 💬
|
| 260 | PDE5 inhibitor | - | - | - | - | [1] 86 86 💬
|
| 261 | PDM608 | - | - | - | - | [1] 6 6 💬
|
| 262 | PDR001 | - | - | - | - | [1] 6 6 💬
|
| 263 | PEA-LUT | - | - | - | - | [1] 127 127 💬
|
| 264 | Peanut | [1] Peanut Peanut | - | - | - | [1] 13 13 💬
|
| 265 | Pectin | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [2] 96 96, 97 💬
|
| 266 | Pednisone | - | - | - | - | [2] 43 43, 44 💬
|
| 267 | Peficitinib | [1] Peficitinib Peficitinib | [1] Peficitinib
Peficitinib
💬
| [3] JAK1 JAK1, JAK2, JAK3 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬
|
| 268 | PEG low volume with bisacodyl | [1] Bisacodyl Bisacodyl | [1] Bisacodyl
Bisacodyl
💬
| - | - | [1] 97 97 💬
|
| 269 | PEG tube | - | - | - | - | [1] 6 6 💬
|
| 270 | Peg-Ada | - | - | - | - | [1] 65 65 💬
|
| 271 | PEG-interferon alfa-2b | [2] Interferon alfa Interferon alfa, Interferon alfa-2b | [2] Interferon alfa-2b
Interferon alfa-2b
,
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 26 26 💬
|
| 272 | Peg-Interferon alpha-2b | - | - | - | - | [1] 34 34 💬
|
| 273 | PEG-interleukin-2 | [1] PEG-interleukin-2 PEG-interleukin-2 | - | - | - | [1] 65 65 💬
|
| 274 | PEG-liposomal Prednisolone Sodium Phosphate | [2] Prednisolone Prednisolone, Prednisolone phosphate | [2] Prednisolone
Prednisolone
,
Prednisolone sodium phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 97 💬
|
| 275 | PEG-rhG-CSF | - | - | - | - | [1] 60 60 💬
|
| 276 | Pegcetacoplam | - | - | - | - | [1] 2 2 💬
|
| 277 | PEGCETACOPLAN | [1] Pegcetacoplan Pegcetacoplan | [1] Pegcetacoplan
Pegcetacoplan
💬
| [1] C3 C3 💬
| [18] Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | [4] 2 2, 61, 62, 223 💬
|
| 278 | Pegcetacoplan (APL-2) | [1] Pegcetacoplan Pegcetacoplan | [1] Pegcetacoplan
Pegcetacoplan
💬
| [1] C3 C3 💬
| [18] Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | [3] 2 2, 61, 62 💬
|
| 279 | Pegfilgrastim | [1] Pegfilgrastim Pegfilgrastim | [1] Pegfilgrastim
Pegfilgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 60 60 💬
|
| 280 | Peginesatide | [1] Peginesatide Peginesatide | [2] Peginesatide
Peginesatide
,
Peginesatide acetate
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 283 283 💬
|
| 281 | Peginterferon alfa-2a | [1] Peginterferon alfa-2a Peginterferon alfa-2a | [1] Peginterferon alfa-2a
Peginterferon alfa-2a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 222 222 💬
|
| 282 | Peginterferon Alfa-2A 180 MCG/ML Injectable Solution | [1] Peginterferon alfa-2a Peginterferon alfa-2a | [1] Peginterferon alfa-2a
Peginterferon alfa-2a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 222 222 💬
|
| 283 | PEGINTERFERON BETA-1A | [1] Peginterferon beta-1a Peginterferon beta-1a | [1] Peginterferon beta-1a
Peginterferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 284 | Peginterferone beta 1a | - | - | - | - | [1] 13 13 💬
|
| 285 | PEGINTERFERONE BETA-1A | - | - | - | - | [1] 13 13 💬
|
| 286 | PEGINTERFERONE LAMBDA-1A | - | - | - | - | [1] 13 13 💬
|
| 287 | Pegsunercept | [1] Pegsunercept Pegsunercept | [1] Pegsunercept
Pegsunercept
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 288 | Pegsunercept (PEG sTNF-RI) | [1] Pegsunercept Pegsunercept | [1] Pegsunercept
Pegsunercept
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 289 | Pegtarviliase | [1] Pegtarviliase Pegtarviliase | - | - | - | [1] 337 337 💬
|
| 290 | Pegtarviliase IV | [1] Pegtarviliase Pegtarviliase | - | - | - | [1] 337 337 💬
|
| 291 | Pegtarviliase SC | [1] Pegtarviliase Pegtarviliase | - | - | - | [1] 337 337 💬
|
| 292 | Pegtibatinase | [1] Pegtibatinase Pegtibatinase | [1] Pegtibatinase
Pegtibatinase
💬
| [1] CBS CBS 💬
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Glycine, serine and threonine metabolism, One carbon pool by folate 💬 | [1] 337 337 💬
|
| 293 | PEGUNIGALSIDASE ALFA | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 294 | Pegunigalsidase alpha | - | - | - | - | [1] 19 19 💬
|
| 295 | Pegunigalsidase-alfa | - | - | - | - | [1] 19 19 💬
|
| 296 | PEGVALIASE | [1] Pegvaliase Pegvaliase | [1] Pegvaliase
Pegvaliase
💬
| [1] PAH PAH 💬
| [3] Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 💬
|
| 297 | Pegvaliase-Pqpz | [1] Pegvaliase Pegvaliase | [1] Pegvaliase
Pegvaliase
💬
| [1] PAH PAH 💬
| [3] Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 💬
|
| 298 | PEGVISOMANT | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 77 77, 265 💬
|
| 299 | Pegvisomant (somavert) | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 300 | Pegvisomant treatment | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 301 | Pegvisomant/ Sandostatin LAR | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 302 | PEGylated Intereron Beta-1a | - | - | - | - | [1] 13 13 💬
|
| 303 | Pegylated interferon alfa | [1] Interferon alfa Interferon alfa | [1] Interferon alfa
Interferon alfa
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 96 96 💬
|
| 304 | Pegylated Interferon Alpha2b | - | - | - | - | [1] 227 227 💬
|
| 305 | PEGylated Interferon Beta-1a | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 306 | PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20 | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 28 28 💬
|
| 307 | Pelubiprofen | [1] Pelubiprofen Pelubiprofen | [1] Pelubiprofen
Pelubiprofen
💬
| - | - | [1] 46 46 💬
|
| 308 | Pelubiprofen 30 mg | [1] Pelubiprofen Pelubiprofen | [1] Pelubiprofen
Pelubiprofen
💬
| - | - | [1] 46 46 💬
|
| 309 | Pelvic Floor Physical Therapy | - | - | - | - | [1] 226 226 💬
|
| 310 | Pemafibrate | [1] Pemafibrate Pemafibrate | [1] Pemafibrate
Pemafibrate
💬
| [1] PPARA PPARA 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 67 67, 93 💬
|
| 311 | Pembrolizumab | [1] Pembrolizumab Pembrolizumab | [1] Pembrolizumab
Pembrolizumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [3] 25 25, 97, 285 💬
|
| 312 | Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection | [1] Pembrolizumab Pembrolizumab | [1] Pembrolizumab
Pembrolizumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [1] 25 25 💬
|
| 313 | PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE | - | - | - | - | [1] 171 171 💬
|
| 314 | PEMIROLAST | [1] Pemirolast Pemirolast | [2] Pemirolast potassium
Pemirolast potassium
,
Pemirolast
💬
| - | - | [1] 113 113 💬
|
| 315 | Pemziviptadil (PB1046) Injection | - | - | - | - | [1] 86 86 💬
|
| 316 | Pending | - | - | - | - | [7] 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 317 | Penicillamine | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [2] 51 51, 171 💬
|
| 318 | Penicillamine (D1-W12) | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 171 171 💬
|
| 319 | Penicillamine (W12-W60) | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 171 171 💬
|
| 320 | PENTAMIDINA ISETIONATO | [1] Pentamidine Pentamidine | [2] Pentamidine isethionate
Pentamidine isethionate
,
Pentamidine
💬
| - | - | [1] 61 61 💬
|
| 321 | Pentamidine | [1] Pentamidine Pentamidine | [2] Pentamidine isethionate
Pentamidine isethionate
,
Pentamidine
💬
| - | - | [1] 61 61 💬
|
| 322 | Pentasa | - | - | - | - | [2] 96 96, 97 💬
|
| 323 | Pentasa 2g sachet prolonged release granules (95%) | - | - | - | - | [1] 97 97 💬
|
| 324 | Pentasa 500 mg Retardtabletten | - | - | - | - | [1] 97 97 💬
|
| 325 | Pentasa Compact 2g, granulate with prolonged release | - | - | - | - | [1] 97 97 💬
|
| 326 | Pentasa Compact 4g, granulate with prolonged release | - | - | - | - | [1] 97 97 💬
|
| 327 | Pentasa enema | - | - | - | - | [1] 97 97 💬
|
| 328 | Pentasa prolonged release granules 2g | - | - | - | - | [1] 97 97 💬
|
| 329 | PENTASA Sachet | - | - | - | - | [2] 96 96, 97 💬
|
| 330 | Pentasa Sachet 1 g | - | - | - | - | [2] 96 96, 97 💬
|
| 331 | Pentasa Sachet 1 g prolonged release granules | - | - | - | - | [1] 96 96 💬
|
| 332 | Pentasa Sachet 1g | - | - | - | - | [1] 97 97 💬
|
| 333 | Pentasa Sachet 2 g | - | - | - | - | [1] 97 97 💬
|
| 334 | Pentetreotide | [1] Pentetreotide Pentetreotide | [1] Pentetreotide
Pentetreotide
💬
| - | - | [1] 75 75 💬
|
| 335 | Pentosan Polysulfat SP 54® injection solution | - | - | - | - | [1] 19 19 💬
|
| 336 | Pentosan polysulfate | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [3] 19 19, 26, 226 💬
|
| 337 | PENTOSAN POLYSULFATE SODIUM | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 338 | Pentosan polysulfate sodium 100 mg | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 226 226 💬
|
| 339 | Pentosan Polysulphate SP54 | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 340 | Pentosan Polysulphate SP54® | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 341 | Pentostatin | [1] Pentostatin Pentostatin | [1] Pentostatin
Pentostatin
💬
| [1] ADA ADA 💬
| [2] Primary immunodeficiency Primary immunodeficiency, Purine metabolism 💬 | [1] 60 60 💬
|
| 342 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [13] 6 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
|
| 343 | Pentoxifylline 400 MG | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [2] 6 6, 97 💬
|
| 344 | Peptid coupled red blood cells | - | - | - | - | [1] 13 13 💬
|
| 345 | Peptide coupled red blood cells | - | - | - | - | [1] 13 13 💬
|
| 346 | Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping | - | - | - | - | [1] 113 113 💬
|
| 347 | Peptide-conjugated phosphorodiamide morpholino oligomer for exon 51 skipping | - | - | - | - | [1] 113 113 💬
|
| 348 | Peptidic+Probiotic | - | - | - | - | [1] 96 96 💬
|
| 349 | Peptison liquid | - | - | - | - | [1] 96 96 💬
|
| 350 | Perampanel | [1] Perampanel Perampanel | [2] Perampanel
Perampanel
,
Perampanel hydrate
💬
| [4] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬
| [17] Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [3] 2 2, 6, 144 💬
|
| 351 | Percutaneous endoscopic gastrostomy tube | - | - | - | - | [1] 6 6 💬
|
| 352 | Percutaneous endoscopic gastrostomy tube (PEG tube) | - | - | - | - | [1] 6 6 💬
|
| 353 | Percutaneous endoscopic gastrostomy with a jejunal (PEG-J) tube | - | - | - | - | [1] 6 6 💬
|
| 354 | Percutaneous Endoscopic Gastrostomy with Jejunal Extension (PEG-J) | - | - | - | - | [1] 6 6 💬
|
| 355 | Percutaneous Lumbar Decompression | - | - | - | - | [1] 70 70 💬
|
| 356 | Percutaneous sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 💬
|
| 357 | Perdix | - | - | - | - | [1] 19 19 💬
|
| 358 | Peresolimab | [1] Peresolimab Peresolimab | [1] Peresolimab
Peresolimab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [1] 46 46 💬
|
| 359 | PERFALGAN | - | - | - | - | [1] 2 2 💬
|
| 360 | Perflubutane | [1] Perflubutane Perflubutane | [1] Perflubutane
Perflubutane
💬
| - | - | [2] 298 298, 300 💬
|
| 361 | Perfluorinated gas/oxygen mixture | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 299 299 💬
|
| 362 | Perflutren | [1] Perflutren Perflutren | [1] Perflutren
Perflutren
💬
| - | - | [2] 2 2, 70 💬
|
| 363 | Perforation of septation and sclerotherapy | - | - | - | - | [1] 278 278 💬
|
| 364 | Perform blood cells and fibroblasts biochemical and immuno-labeled investigations | - | - | - | - | [1] 265 265 💬
|
| 365 | Perform three multiple breath nitrogen washout tests (N2-MBW-test) | [1] Nitrogen Nitrogen | [1] Nitrogen
Nitrogen
💬
| - | - | [1] 299 299 💬
|
| 366 | Perfusion of treatment Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 367 | Perfusion of treatment Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 368 | PERGOLIDE | [1] Pergolide Pergolide | [2] Pergolide mesylate
Pergolide mesylate
,
Pergolide
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 369 | Perhexiline | [1] Perhexiline Perhexiline | [2] Perhexiline maleate
Perhexiline maleate
,
Perhexiline
💬
| [8] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬
| [47] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Fatty acid degradation, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 58 58, 272 💬
|
| 370 | Peri-neural Dexamethasone 1 mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 371 | Peridopril arginine | [1] Arginine Arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [1] 57 57 💬
|
| 372 | Perindopril | [1] Perindopril Perindopril | [3] Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [5] 57 57, 58, 113, 167, 222 💬
|
| 373 | Perindopril 2mg Tablets | [1] Perindopril Perindopril | [3] Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 113 113 💬
|
| 374 | PERINDOPRIL ARGININA | [2] Arginine Arginine, Perindopril | [6] Perindopril erbumine
Perindopril erbumine
,
Arginine hydrochloride
,
Arginine
,
Perindopril
,
Arginine hydrochloride
,
Perindopril arginine
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 58 58 💬
|
| 375 | PERINDOPRIL ARGININE | [2] Arginine Arginine, Perindopril | [6] Perindopril erbumine
Perindopril erbumine
,
Arginine hydrochloride
,
Arginine
,
Perindopril
,
Arginine hydrochloride
,
Perindopril arginine
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [2] 57 57, 58 💬
|
| 376 | Period 1 IBI112 dose 1 | - | - | - | - | [1] 97 97 💬
|
| 377 | Period 1 IBI112 dose 2 | - | - | - | - | [1] 97 97 💬
|
| 378 | Period 2 IBI112 dose 3 | - | - | - | - | [1] 97 97 💬
|
| 379 | Period 2 IBI112 dose 4 | - | - | - | - | [1] 97 97 💬
|
| 380 | Periodontal Examination | - | - | - | - | [1] 46 46 💬
|
| 381 | Peripheral blood sampling, bronchoscopy, upper airway and faeces sampling | - | - | - | - | [1] 84 84 💬
|
| 382 | Peripheral blood stem cell | - | - | - | - | [1] 285 285 💬
|
| 383 | Peripheral Blood Stem Cell Infusion | - | - | - | - | [1] 96 96 💬
|
| 384 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 385 | Peripheral blood stem cell transplantation (PBSCT) | - | - | - | - | [1] 60 60 💬
|
| 386 | Peripheral Blood Stem Cells | - | - | - | - | [2] 51 51, 65 💬
|
| 387 | Peripheral blood withdrawal | - | - | - | - | [1] 13 13 💬
|
| 388 | Peripheral venous blood sample | - | - | - | - | [1] 329 329 💬
|
| 389 | Permitted DMARDs | - | - | - | - | [1] 46 46 💬
|
| 390 | Persantin 100 mg | - | - | - | - | [1] 46 46 💬
|
| 391 | Persantin 100 mg and | - | - | - | - | [1] 46 46 💬
|
| 392 | Personalized Ayurveda treatment protocol | - | - | - | - | [1] 46 46 💬
|
| 393 | Personalized extended interval dosing of natalizumab | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 394 | PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE | [1] Aluminium Aluminium | - | - | - | [1] 46 46 💬
|
| 395 | PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE | [1] Aluminium Aluminium | - | - | - | [1] 46 46 💬
|
| 396 | PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE | [1] Aluminium Aluminium | - | - | - | [1] 46 46 💬
|
| 397 | Pertussis vaccine | [1] Pertussis vaccine Pertussis vaccine | [1] Pertussis vaccine
Pertussis vaccine
💬
| - | - | [2] 13 13, 46 💬
|
| 398 | PERTZYE | - | - | - | - | [1] 299 299 💬
|
| 399 | Perxexiline | - | - | - | - | [1] 58 58 💬
|
| 400 | PET | - | - | - | - | [1] 6 6 💬
|
| 401 | PET with 11C-Flumazenil | [1] Flumazenil Flumazenil | [1] Flumazenil
Flumazenil
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 💬
|
| 402 | PET/CT | - | - | - | - | [1] 6 6 💬
|
| 403 | PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | - | - | - | - | [1] 85 85 💬
|
| 404 | PET10 | - | - | - | - | [1] 41 41 💬
|
| 405 | PET3 | - | - | - | - | [1] 41 41 💬
|
| 406 | Petrolatum | [1] Petrolatum Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [3] 35 35, 158, 162 💬
|
| 407 | Pexsig | - | - | - | - | [1] 58 58 💬
|
| 408 | PF 06687234 | - | - | - | - | [2] 96 96, 97 💬
|
| 409 | PF-00489791 | [1] PF-00489791 PF-00489791 | - | - | - | [1] 86 86 💬
|
| 410 | PF-00547659 | - | - | - | - | [2] 96 96, 97 💬
|
| 411 | PF-00547659 SC injection | - | - | - | - | [2] 96 96, 97 💬
|
| 412 | PF-02545920 | - | - | - | - | [1] 8 8 💬
|
| 413 | PF-04171327 | - | - | - | - | [1] 46 46 💬
|
| 414 | PF-04171327 10 mg | - | - | - | - | [1] 46 46 💬
|
| 415 | PF-04171327 25 mg | - | - | - | - | [1] 46 46 💬
|
| 416 | PF-04236921 | - | - | - | - | [2] 49 49, 96 💬
|
| 417 | PF-04236921 SC injection | - | - | - | - | [1] 96 96 💬
|
| 418 | PF-04383119 | - | - | - | - | [1] 226 226 💬
|
| 419 | PF-04950615 | - | - | - | - | [1] 79 79 💬
|
| 420 | PF-05208763 | - | - | - | - | [1] 67 67 💬
|
| 421 | PF-05230917 | - | - | - | - | [1] 97 97 💬
|
| 422 | PF-05280586 | - | - | - | - | [1] 46 46 💬
|
| 423 | PF-05285401 | - | - | - | - | [1] 97 97 💬
|
| 424 | PF-06252616 | - | - | - | - | [1] 113 113 💬
|
| 425 | PF-06291826-00 | - | - | - | - | [1] 28 28 💬
|
| 426 | PF-06291826-83 | - | - | - | - | [1] 28 28 💬
|
| 427 | PF-06291826-83, Fx-1006A | [1] Fx-1006A Fx-1006A | - | - | - | [1] 28 28 💬
|
| 428 | PF-06291826-83/Fx-1006A | [1] Fx-1006A Fx-1006A | - | - | - | [1] 28 28 💬
|
| 429 | PF-06342674 0.25 mg/kg | - | - | - | - | [1] 13 13 💬
|
| 430 | PF-06342674 1.5 mg/kg | - | - | - | - | [1] 13 13 💬
|
| 431 | PF-06342674 6.0 mg/kg | - | - | - | - | [1] 13 13 💬
|
| 432 | PF-06410293 | - | - | - | - | [1] 46 46 💬
|
| 433 | PF-06412562 | - | - | - | - | [1] 6 6 💬
|
| 434 | PF-06438179 | - | - | - | - | [1] 46 46 💬
|
| 435 | PF-06462700 | - | - | - | - | [1] 60 60 💬
|
| 436 | PF-06480605 | - | - | - | - | [1] 97 97 💬
|
| 437 | PF-06480605 100 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 438 | PF-06649751 | [1] Tavapadon Tavapadon | [1] Tavapadon
Tavapadon
💬
| [2] DRD1 DRD1, DRD5 💬
| [12] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 439 | PF-06649751 - 15mg | - | - | - | - | [1] 6 6 💬
|
| 440 | PF-06649751 - 1mg | - | - | - | - | [1] 6 6 💬
|
| 441 | PF-06649751 - 5mg | - | - | - | - | [1] 6 6 💬
|
| 442 | PF-06649751 high dose (15 mg QD) | - | - | - | - | [1] 6 6 💬
|
| 443 | PF-06649751 low dose (1 mg QD) | - | - | - | - | [1] 6 6 💬
|
| 444 | PF-06649751 middle dose 1 (3 mg QD) | - | - | - | - | [1] 6 6 💬
|
| 445 | PF-06649751 middle dose 2 (7 mg QD) | - | - | - | - | [1] 6 6 💬
|
| 446 | PF-06650833 | - | - | - | - | [1] 46 46 💬
|
| 447 | PF-06650833 100 mg | - | - | - | - | [1] 46 46 💬
|
| 448 | PF-06650833 20 mg | - | - | - | - | [1] 46 46 💬
|
| 449 | PF-06651600 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 450 | PF-06651600 10 mg | - | - | - | - | [1] 97 97 💬
|
| 451 | PF-06651600 50 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 452 | PF-06651600 50mg | - | - | - | - | [1] 96 96 💬
|
| 453 | PF-06651600-15 | - | - | - | - | [2] 96 96, 97 💬
|
| 454 | PF-06669571 | - | - | - | - | [1] 6 6 💬
|
| 455 | PF-06687234 | - | - | - | - | [1] 97 97 💬
|
| 456 | PF-06700841 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 457 | PF-06700841 15 mg | - | - | - | - | [1] 49 49 💬
|
| 458 | PF-06700841 25 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 459 | PF-06700841 25mg | - | - | - | - | [1] 49 49 💬
|
| 460 | PF-06700841 30 mg | - | - | - | - | [1] 49 49 💬
|
| 461 | PF-06700841 45 mg | - | - | - | - | [1] 49 49 💬
|
| 462 | PF-06700841 5 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 463 | PF-06700841 5mg | - | - | - | - | [1] 49 49 💬
|
| 464 | PF-06700841-15 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 465 | PF-06730512 | - | - | - | - | [1] 222 222 💬
|
| 466 | PF-06755347 intravenous healthy participant | - | - | - | - | [1] 63 63 💬
|
| 467 | PF-06755347 subcutaneous healthy participant | - | - | - | - | [1] 63 63 💬
|
| 468 | PF-06755347 subcutaneous ITP | - | - | - | - | [1] 63 63 💬
|
| 469 | PF-06823859 | - | - | - | - | [1] 50 50 💬
|
| 470 | PF-06823859 high | - | - | - | - | [1] 50 50 💬
|
| 471 | PF-06823859 low | - | - | - | - | [1] 50 50 💬
|
| 472 | PF-06826647 | - | - | - | - | [1] 97 97 💬
|
| 473 | PF-06826647 100 mg QD | - | - | - | - | [1] 97 97 💬
|
| 474 | PF-06826647 300 mg QD | - | - | - | - | [1] 97 97 💬
|
| 475 | PF-06826647 600 mg QD | - | - | - | - | [1] 97 97 💬
|
| 476 | PF-06835375 | - | - | - | - | [3] 46 46, 49, 63 💬
|
| 477 | PF-06939926 | - | - | - | - | [1] 113 113 💬
|
| 478 | PF-07054894 | - | - | - | - | [1] 97 97 💬
|
| 479 | PF-07256472 | - | - | - | - | [1] 276 276 💬
|
| 480 | PF-07265803 | - | - | - | - | [1] 57 57 💬
|
| 481 | PF-07868489 | - | - | - | - | [1] 86 86 💬
|
| 482 | PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2- | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 483 | PF-6826647 400 mg QD | - | - | - | - | [1] 97 97 💬
|
| 484 | PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 💬
|
| 485 | Pfefferminzblätter 1ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 486 | Pfizer Comirnaty vaccine | - | - | - | - | [1] 97 97 💬
|
| 487 | PFP | - | - | - | - | [1] 299 299 💬
|
| 488 | PFP and SF6 Human Lung Coil | - | - | - | - | [1] 299 299 💬
|
| 489 | PFT | - | - | - | - | [1] 89 89 💬
|
| 490 | PG-760564 | - | - | - | - | [1] 46 46 💬
|
| 491 | PG2 | - | - | - | - | [1] 63 63 💬
|
| 492 | PG203 | - | - | - | - | [1] 6 6 💬
|
| 493 | PGD granules | - | - | - | - | [1] 74 74 💬
|
| 494 | PGM169/GL67A | - | - | - | - | [1] 299 299 💬
|
| 495 | PGN-EDO51 | - | - | - | - | [1] 113 113 💬
|
| 496 | PGN-EDODM1 | - | - | - | - | [1] 113 113 💬
|
| 497 | PGN-EDODM1 for infusion | - | - | - | - | [1] 113 113 💬
|
| 498 | PGz Bed | - | - | - | - | [1] 21 21 💬
|
| 499 | PH-797804 | [1] PH-797804 PH-797804 | - | - | - | [1] 46 46 💬
|
| 500 | Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | [1] Propanoic acid Propanoic acid | [3] Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | [1] 6 6 💬
|
| 501 | Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid | - | - | - | - | [1] 6 6 💬
|
| 502 | PHA-022121 | - | - | - | - | [1] 65 65 💬
|
| 503 | PHA-022121 Monohydrate | - | - | - | - | [1] 65 65 💬
|
| 504 | Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells | - | - | - | - | [1] 65 65 💬
|
| 505 | Pharmacodynamics | - | - | - | - | [1] 34 34 💬
|
| 506 | Pharmacokinetics of certolizumab pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 507 | Pharmacokinetics study | - | - | - | - | [1] 50 50 💬
|
| 508 | Pharmacologic approaches to glycemic treatment | - | - | - | - | [1] 298 298 💬
|
| 509 | Pharmacopuncture | - | - | - | - | [1] 70 70 💬
|
| 510 | Pharmacotherapy(antiparkinsonian drugs) | - | - | - | - | [1] 6 6 💬
|
| 511 | PHASE 1 Lowenstein medical BiLevel Prisma 25ST device: withount oxygen support. | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 230 230 💬
|
| 512 | Phase 1, SQY51 | - | - | - | - | [1] 113 113 💬
|
| 513 | Phase 1: Conventiaonal DMARD | - | - | - | - | [1] 46 46 💬
|
| 514 | Phase 1: Etanercept | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 515 | Phase 1: Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 516 | Phase 1a: OCT-980 Capsule | - | - | - | - | [1] 90 90 💬
|
| 517 | Phase 1b/2: OCT-980 Tablet | - | - | - | - | [1] 90 90 💬
|
| 518 | Phase 2 | - | - | - | - | [1] 13 13 💬
|
| 519 | PHASE 2. Continous/Bilevel positive airway presure with additional oxygen support by Devilbiss 525 KS oxygen concentrator | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 230 230 💬
|
| 520 | Phase 2: Optional ETN, SSZ, HCQ, MTX | - | - | - | - | [1] 46 46 💬
|
| 521 | Phase 2a, SQY51 (cohort 1) | - | - | - | - | [1] 113 113 💬
|
| 522 | Phase 2a, SQY51 (cohort 2) | - | - | - | - | [1] 113 113 💬
|
| 523 | Phase 2a, SQY51 (cohort 3) | - | - | - | - | [1] 113 113 💬
|
| 524 | Phase 3 | - | - | - | - | [1] 13 13 💬
|
| 525 | Phase1 : CDED/Modulen™IBD® + Maintenance therapy | - | - | - | - | [1] 96 96 💬
|
| 526 | Phase2 and 3 : | - | - | - | - | [1] 96 96 💬
|
| 527 | Pheburane | - | - | - | - | [1] 21 21 💬
|
| 528 | PheCheck | - | - | - | - | [1] 240 240 💬
|
| 529 | Phenlarmide Tablets | - | - | - | - | [1] 6 6 💬
|
| 530 | Phenoptin | - | - | - | - | [2] 124 124, 240 💬
|
| 531 | Phenothiazine | [1] Phenothiazine Phenothiazine | [1] Phenothiazine
Phenothiazine
💬
| - | - | [1] 127 127 💬
|
| 532 | Phenserine | [1] Phenserine Phenserine | - | - | - | [1] 6 6 💬
|
| 533 | Phentermine | [1] Phentermine Phentermine | [2] Phentermine
Phentermine
,
Phentermine hydrochloride
💬
| [5] MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬
| [16] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 97 97 💬
|
| 534 | Phentermine-Topiramate | [2] Phentermine Phentermine, Topiramate | [3] Topiramate
Topiramate
,
Phentermine
,
Phentermine hydrochloride
💬
| [42] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, MAOA, MAOB, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SLC6A2, SLC6A3, SLC6A4 💬
| [65] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, IgSF CAM signaling, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 535 | Phenylalanine | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 536 | Phenylalanine (Phe) | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 537 | Phenylalanine restricted diet | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 538 | Phenylalanine-free milk | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 539 | Phenylalanine-free protein substitute in tablet form (XPhe minis) | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 540 | Phenylalanine-free protein substitute tablets | [1] Phenylalanine Phenylalanine | [1] Phenylalanine
Phenylalanine
💬
| - | - | [1] 240 240 💬
|
| 541 | PHENYLBUTYRATE | - | - | - | - | [2] 2 2, 244 💬
|
| 542 | Phenylbutyrate Oral Tablet | - | - | - | - | [1] 15 15 💬
|
| 543 | PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 13 13 💬
|
| 544 | Phenylephrine | [1] Phenylephrine Phenylephrine | [3] Phenylephrine hydrochloride
Phenylephrine hydrochloride
,
Phenylephrine
,
Phenylephrine bitartrate
💬
| [3] ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 22 22 💬
|
| 545 | Phenylketonuria-type diet | - | - | - | - | [1] 240 240 💬
|
| 546 | Phenytoin | [1] Phenytoin Phenytoin | [2] Phenytoin
Phenytoin
,
Phenytoin sodium
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 13 13 💬
|
| 547 | Pheripheral blood stem cells | - | - | - | - | [1] 65 65 💬
|
| 548 | PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | [1] Propanoic acid Propanoic acid | [3] Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | [1] 6 6 💬
|
| 549 | PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid | - | - | - | - | [1] 6 6 💬
|
| 550 | Phlebotomy | - | - | - | - | [4] 89 89, 158, 254, 340 💬
|
| 551 | Phosphate and betamethasone acetate, 2 mL. | [2] Acetate Acetate, Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 💬
|
| 552 | Phosphate Buffer Saline (PBS), | - | - | - | - | [1] 65 65 💬
|
| 553 | Phosphate Buffer Saline (PBS), pH 7.0 | - | - | - | - | [1] 65 65 💬
|
| 554 | Phosphate tablets. | - | - | - | - | [1] 238 238 💬
|
| 555 | Phosphate-buffered saline | - | - | - | - | [1] 49 49 💬
|
| 556 | Phosphate. | - | - | - | - | [1] 238 238 💬
|
| 557 | Phosphatidylcholine | - | - | - | - | [1] 97 97 💬
|
| 558 | Phosphodiesterase Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 559 | Phosphorodiamidate Morpholino Oligomer | - | - | - | - | [1] 113 113 💬
|
| 560 | Phosphorodiamidate morpholino oligomer for exon 45 skipping | - | - | - | - | [1] 113 113 💬
|
| 561 | Phosphorodiamidate morpholino oligomer for exon 53 skipping | - | - | - | - | [1] 113 113 💬
|
| 562 | Phosphorus | [1] Phosphorus Phosphorus | - | - | - | [2] 8 8, 238 💬
|
| 563 | Photodynamic therapy with Gliolan | - | - | - | - | [1] 97 97 💬
|
| 564 | Phototherapy (Bright Light) | - | - | - | - | [1] 202 202 💬
|
| 565 | PHP-303 | - | - | - | - | [1] 231 231 💬
|
| 566 | PHVS416 | - | - | - | - | [1] 65 65 💬
|
| 567 | Phylloquinone | [1] Phylloquinone Phylloquinone | [1] Phytonadione
Phytonadione
💬
| - | - | [1] 96 96 💬
|
| 568 | Phylloquinone (vitamin K1) | [1] Phylloquinone Phylloquinone | [1] Phytonadione
Phytonadione
💬
| - | - | [1] 96 96 💬
|
| 569 | Physical Exam | - | - | - | - | [2] 215 215, 216 💬
|
| 570 | Physical examination and Urine and blood samples | - | - | - | - | [1] 179 179 💬
|
| 571 | Physician standard-of-care | - | - | - | - | [1] 96 96 💬
|
| 572 | Physiologic serum nebulized nasally | - | - | - | - | [1] 299 299 💬
|
| 573 | Physiological saline | - | - | - | - | [1] 51 51 💬
|
| 574 | Physiological serum (Sodium chloride) | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 193 193 💬
|
| 575 | Physiological solution | - | - | - | - | [1] 299 299 💬
|
| 576 | PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung | - | - | - | - | [1] 227 227 💬
|
| 577 | Physiologische Kochsalzlösung Fresenius - Infusionslösung | - | - | - | - | [1] 288 288 💬
|
| 578 | Physiotherapy, exercise, percutaneous gastrostomy feeds | - | - | - | - | [1] 299 299 💬
|
| 579 | Phytomenadione | - | - | - | - | [1] 288 288 💬
|
| 580 | Phytosterol | - | - | - | - | [1] 79 79 💬
|
| 581 | PI-0824 | [1] PI-0824 PI-0824 | - | - | - | [1] 35 35 💬
|
| 582 | PI-2301 | - | - | - | - | [1] 13 13 💬
|
| 583 | Picibanil | [1] Picibanil Picibanil | [1] Picibanil
Picibanil
💬
| - | - | [1] 278 278 💬
|
| 584 | Piclidenoson | [1] Piclidenoson Piclidenoson | [1] Piclidenoson
Piclidenoson
💬
| [1] ADORA3 ADORA3 💬
| [4] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 46 46, 348 💬
|
| 585 | Piclozotan | [1] Piclozotan Piclozotan | - | - | - | [1] 6 6 💬
|
| 586 | Pig whipworm eggs | - | - | - | - | [1] 46 46 💬
|
| 587 | Pilocarpine | [1] Pilocarpine Pilocarpine | [3] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [3] 6 6, 53, 299 💬
|
| 588 | Pilocarpine Hydrochloride | [1] Pilocarpine Pilocarpine | [3] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 53 53 💬
|
| 589 | Pilocarpine Iontophoresis | [1] Pilocarpine Pilocarpine | [3] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 590 | Pilocarpine microneedle patch | [1] Pilocarpine Pilocarpine | [3] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 591 | Pilocarpine Nitrate 5% | [2] Nitrate Nitrate, Pilocarpine | [4] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Nitric acid
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 592 | PIMAVANSERIN | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 593 | Pimavanserin (ACP-103) | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 594 | Pimavanserin 34 mg | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 595 | PIMAVANSERIN TARTRATE | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 596 | Pimavanserin tartrate (ACP-103) | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 597 | Pimecrolimus | [1] Pimecrolimus Pimecrolimus | [1] Pimecrolimus
Pimecrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 160 160 💬
|
| 598 | Pimecrolimus 1% Cream | [1] Pimecrolimus Pimecrolimus | [1] Pimecrolimus
Pimecrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 160 160 💬
|
| 599 | Pimozide | [1] Pimozide Pimozide | [1] Pimozide
Pimozide
💬
| [2] ADRA2A ADRA2A, DRD2 💬
| [11] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
| 600 | Pimozide 2 mg per day | [1] Pimozide Pimozide | [1] Pimozide
Pimozide
💬
| [2] ADRA2A ADRA2A, DRD2 💬
| [11] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
| 601 | Pimozide 2mg/day (current) or 4 mg/day (study initiation) | [1] Pimozide Pimozide | [1] Pimozide
Pimozide
💬
| [2] ADRA2A ADRA2A, DRD2 💬
| [11] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
| 602 | Pimozide 4 mg per day | [1] Pimozide Pimozide | [1] Pimozide
Pimozide
💬
| [2] ADRA2A ADRA2A, DRD2 💬
| [11] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
| 603 | Pinaverium | [1] Pinaverium Pinaverium | [1] Pinaverium bromide
Pinaverium bromide
💬
| [1] CACNA1S CACNA1S 💬
| [27] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, GABAergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 298 298 💬
|
| 604 | Pinaverium bromide | [1] Pinaverium Pinaverium | [1] Pinaverium bromide
Pinaverium bromide
💬
| [1] CACNA1S CACNA1S 💬
| [27] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, GABAergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 298 298 💬
|
| 605 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
|
| 606 | Pioglitazone (ACTOS®) | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 223 223 💬
|
| 607 | Pioglitazone (PIO) | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 298 298 💬
|
| 608 | Pioglitazone 15 mg | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 96 96 💬
|
| 609 | Pioglitazone and Tretinoin | [2] Pioglitazone Pioglitazone, Tretinoin | [3] Tretinoin
Tretinoin
,
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [4] PML PML, PPARG, RARA, RARB 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Efferocytosis, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | [1] 2 2 💬
|
| 610 | Pioglitazone or metformin | [2] Metformin Metformin, Pioglitazone | [4] Metformin hydrochloride
Metformin hydrochloride
,
Pioglitazone hydrochloride
,
Metformin
,
Pioglitazone
💬
| [3] PPARG PPARG, PRKAA1, PRKAA2 💬
| [28] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Efferocytosis, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 265 265 💬
|
| 611 | PIPE-307 | - | - | - | - | [1] 13 13 💬
|
| 612 | PIPE-307 Dose A | - | - | - | - | [1] 13 13 💬
|
| 613 | PIPE-307 Dose B | - | - | - | - | [1] 13 13 💬
|
| 614 | PIPE-791 | - | - | - | - | [2] 13 13, 85 💬
|
| 615 | PIPE-791 Dose A | - | - | - | - | [1] 85 85 💬
|
| 616 | PIPE-791 Dose B | - | - | - | - | [1] 85 85 💬
|
| 617 | PIPERACILLIN | [1] Piperacillin Piperacillin | [3] Piperacillin sodium
Piperacillin sodium
,
Piperacillin
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 618 | PIPERACILLIN SODIUM | [1] Piperacillin Piperacillin | [3] Piperacillin sodium
Piperacillin sodium
,
Piperacillin
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 619 | Piperacillin sodium , tazobactam sodium | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 620 | Piperacillin with Tazobactam (tazocin) | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 621 | Piperacillin-tazobactam combination product | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 622 | Piperacillin/Tazobactam | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 623 | Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 624 | Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie | [1] Tazobactam Tazobactam | [2] Tazobactam
Tazobactam
,
Tazobactam sodium
💬
| - | - | [1] 299 299 💬
|
| 625 | Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie | [1] Tazobactam Tazobactam | [2] Tazobactam
Tazobactam
,
Tazobactam sodium
💬
| - | - | [1] 299 299 💬
|
| 626 | Piperazine | [1] Piperazine Piperazine | [5] Piperazine
Piperazine
,
Piperazine phosphate
,
Piperazine citrate
,
Piperazine adipate
,
Piperazine hexahydrate
💬
| - | - | [2] 58 58, 272 💬
|
| 627 | PIR, S-7701 | - | - | - | - | [1] 85 85 💬
|
| 628 | Pirepemat | [1] Pirepemat Pirepemat | - | - | - | [1] 6 6 💬
|
| 629 | Pirepemat x fumarate | [1] Pirepemat Pirepemat | - | - | - | [1] 6 6 💬
|
| 630 | Pirepemat, 100 mg | [1] Pirepemat Pirepemat | - | - | - | [1] 6 6 💬
|
| 631 | Pirepemat, 50 mg | [1] Pirepemat Pirepemat | - | - | - | [1] 6 6 💬
|
| 632 | Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [12] 13 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 633 | Pirfenidone (PFD) | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 51 51, 85 💬
|
| 634 | Pirfenidone 267 MG [Esbriet] | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 228 228 💬
|
| 635 | Pirfenidone and nintedanib | [2] Nintedanib Nintedanib, Pirfenidone | [3] Pirfenidone
Pirfenidone
,
Nintedanib esylate
,
Nintedanib
💬
| [14] CCL2 CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬
| [108] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 636 | Pirfenidone Capsules | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 40 40 💬
|
| 637 | Pirfenidone Modified-Release Tablets | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 638 | Pirfenidone or nintedanib | [2] Nintedanib Nintedanib, Pirfenidone | [3] Pirfenidone
Pirfenidone
,
Nintedanib esylate
,
Nintedanib
💬
| [14] CCL2 CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬
| [108] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 639 | Pirfenidone Solution for Inhalation | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 640 | Pirfenidone Tablets | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 641 | Pirfenidone, deuterated | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 642 | Pirfenidoneone | - | - | - | - | [1] 85 85 💬
|
| 643 | Piribedil | [1] Piribedil Piribedil | [1] Piribedil
Piribedil
💬
| [2] DRD2 DRD2, DRD3 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 644 | Piribedil (Clarium) | [1] Piribedil Piribedil | [1] Piribedil
Piribedil
💬
| [2] DRD2 DRD2, DRD3 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 645 | Pirtobrutinib | [1] Pirtobrutinib Pirtobrutinib | [1] Pirtobrutinib
Pirtobrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 13 13, 63 💬
|
| 646 | PIT565 | - | - | - | - | [2] 46 46, 49 💬
|
| 647 | Pitavastatin | [1] Pitavastatin Pitavastatin | [2] Pitavastatin calcium
Pitavastatin calcium
,
Pitavastatin magnesium
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [4] 49 49, 71, 79, 90 💬
|
| 648 | PITAVASTATIN CALCIUM | [2] Calcium Calcium, Pitavastatin | [2] Pitavastatin calcium
Pitavastatin calcium
,
Pitavastatin magnesium
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 649 | Pitolisant | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 113, 193 💬
|
| 650 | Pitolisant Oral Tablet | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 113 113 💬
|
| 651 | Pitolisant oral tablets | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 193 193 💬
|
| 652 | Pitolisant tablet | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 193 193 💬
|
| 653 | Pittsburgh Compound B | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [3] 6 6, 13, 127 💬
|
| 654 | Pittsburgh Compound B (C-11 PiB) | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 127 127 💬
|
| 655 | PIXANTRONE | [1] Pixantrone Pixantrone | [2] Pixantrone
Pixantrone
,
Pixantrone dimaleate
💬
| - | - | [2] 11 11, 13 💬
|
| 656 | PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 657 | PK-model to decide when to dose Vedolizumab and Ustekinumab | [2] Ustekinumab Ustekinumab, Vedolizumab | [2] Vedolizumab
Vedolizumab
,
Ustekinumab
💬
| [5] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7 💬
| [45] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 658 | PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease | [1] Digoxin Digoxin | [1] Digoxin
Digoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬
|
| 659 | PKU EASY Microtabs Plus | - | - | - | - | [1] 240 240 💬
|
| 660 | PKU Explore | - | - | - | - | [1] 240 240 💬
|
| 661 | PKU express plus | - | - | - | - | [2] 244 244, 337 💬
|
| 662 | PKU GOLIKE | - | - | - | - | [1] 240 240 💬
|
| 663 | PKU Sphere | - | - | - | - | [1] 240 240 💬
|
| 664 | PKU sphere liquid | - | - | - | - | [1] 240 240 💬
|
| 665 | PKU Start | - | - | - | - | [1] 240 240 💬
|
| 666 | PKU UP | - | - | - | - | [1] 240 240 💬
|
| 667 | PKU/TYR GMP Protein Substitute | - | - | - | - | [1] 240 240 💬
|
| 668 | PL 00095/5079R | - | - | - | - | [1] 46 46 💬
|
| 669 | PL 0010/0211 | - | - | - | - | [1] 299 299 💬
|
| 670 | PL 00512/0150 | - | - | - | - | [1] 298 298 💬
|
| 671 | PL 04515/0127 | - | - | - | - | [1] 13 13 💬
|
| 672 | PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION) | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 57 57 💬
|
| 673 | PL 12762/0049 | - | - | - | - | [1] 13 13 💬
|
| 674 | PL 17901/0122 | - | - | - | - | [1] 96 96 💬
|
| 675 | PL 20532/0012 | - | - | - | - | [1] 96 96 💬
|
| 676 | PL101 | - | - | - | - | [1] 8 8 💬
|
| 677 | PL8177 | - | - | - | - | [1] 97 97 💬
|
| 678 | PLA + MTX switched to ABA+ MTX, DB | - | - | - | - | [1] 46 46 💬
|
| 679 | PLA-695 | - | - | - | - | [1] 46 46 💬
|
| 680 | PLA-PRU-PLA-PRU | - | - | - | - | [1] 99 99 💬
|
| 681 | PLA-PRU-PRU-PLA | - | - | - | - | [1] 99 99 💬
|
| 682 | Placental Mesenchymal Stem Cells | [1] Placental Mesenchymal Stem Cells Placental Mesenchymal Stem Cells | - | - | - | [1] 118 118 💬
|
| 683 | Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix | [1] Placental Mesenchymal Stem Cells Placental Mesenchymal Stem Cells | - | - | - | [1] 118 118 💬
|
| 684 | PLACENTEX ® Polydeoxyribonucleotide | - | - | - | - | [1] 51 51 💬
|
| 685 | PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml | - | - | - | - | [1] 51 51 💬
|
| 686 | PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿ | - | - | - | - | [1] 51 51 💬
|
| 687 | Plaebo | - | - | - | - | [1] 46 46 💬
|
| 688 | Plamotamab | [1] Plamotamab Plamotamab | [1] Plamotamab
Plamotamab
💬
| [2] CD3E CD3E, MS4A1 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 46 46 💬
|
| 689 | Planar Image with both Hands in Field of View | - | - | - | - | [1] 46 46 💬
|
| 690 | Plant cell expressed recombinant glucocerebrosidase (prGCD) | - | - | - | - | [1] 19 19 💬
|
| 691 | Plant Cell Recombinant Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 692 | Plantago ovata husk | - | - | - | - | [1] 6 6 💬
|
| 693 | Plantain NSP | - | - | - | - | [1] 96 96 💬
|
| 694 | PLAQUENIL | - | - | - | - | [6] 46 46, 48, 49, 53, 84, 96 💬
|
| 695 | Plaquenil - Hydroxychloroquine 200mg Film coated tablets | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [3] 43 43, 44, 45 💬
|
| 696 | Plaquenil 200 mg filmdrasjerte tabletter | - | - | - | - | [1] 46 46 💬
|
| 697 | Plaquenil 200Mg Tablet | - | - | - | - | [1] 48 48 💬
|
| 698 | PLAQUENIL*25CPR RIV 200MG | - | - | - | - | [1] 84 84 💬
|
| 699 | Plasma analysis for bacterial translocation | - | - | - | - | [1] 46 46 💬
|
| 700 | Plasma exchange | - | - | - | - | [7] 13 13, 43, 44, 64, 95, 171, 222 💬
|
| 701 | Plasma exchange (PE) | - | - | - | - | [6] 11 11, 13, 64, 66, 221, 223 💬
|
| 702 | Plasma exchange (PLEX) | - | - | - | - | [1] 221 221 💬
|
| 703 | Plasma from healthy young people treatment + Riluzole | [1] Riluzole Riluzole | [1] Riluzole
Riluzole
💬
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 704 | Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI) | - | - | - | - | [1] 96 96 💬
|
| 705 | Plasmapheresis | - | - | - | - | [4] 11 11, 49, 113, 222 💬
|
| 706 | PLASMASAFE | - | - | - | - | [1] 274 274 💬
|
| 707 | PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML | - | - | - | - | [1] 274 274 💬
|
| 708 | Platelet Concentrate | - | - | - | - | [1] 63 63 💬
|
| 709 | Platelet enriched plasma | - | - | - | - | [1] 226 226 💬
|
| 710 | Platelet Gel | - | - | - | - | [1] 51 51 💬
|
| 711 | Platelet Rich Plasma | [1] Platelet Rich Plasma Platelet Rich Plasma | - | - | - | [6] 35 35, 46, 47, 70, 90, 269 💬
|
| 712 | Platelet rich plasma therapy | [1] Platelet Rich Plasma Platelet Rich Plasma | - | - | - | [1] 269 269 💬
|
| 713 | Platelet transfusion | - | - | - | - | [1] 13 13 💬
|
| 714 | Platelet-Rich Plasma | - | - | - | - | [1] 226 226 💬
|
| 715 | Platform | - | - | - | - | [1] 13 13 💬
|
| 716 | Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons) | [4] Acetate Acetate, Dimethyl fumarate, Glatiramer, Teriflunomide | [3] Dimethyl fumarate
Dimethyl fumarate
,
Glatiramer acetate
,
Teriflunomide
💬
| [22] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, KEAP1 💬
| [39] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Parkinson disease, Pathways in cancer, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
| 717 | Platinum | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 718 | Platinum Compound | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 719 | Platinum Doublet | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 720 | Plavix | - | - | - | - | [1] 51 51 💬
|
| 721 | Plcacebo | - | - | - | - | [1] 67 67 💬
|
| 722 | PLECONARIL | [1] Pleconaril Pleconaril | [1] Pleconaril
Pleconaril
💬
| - | - | [1] 2 2 💬
|
| 723 | PLEDIGRY | - | - | - | - | [1] 13 13 💬
|
| 724 | Plegridy | - | - | - | - | [1] 13 13 💬
|
| 725 | Plegridy (Peg IFNbeta-1-a, Biogen Netherlands B.V) | - | - | - | - | [1] 13 13 💬
|
| 726 | Plegridy (Peg IFNß-1-a, Biogen Netherlands B.V) | - | - | - | - | [1] 13 13 💬
|
| 727 | Plegridy (peginterferon beta-1a), Biogen Idec Ltd | [1] Peginterferon beta-1a Peginterferon beta-1a | [1] Peginterferon beta-1a
Peginterferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 728 | PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE | - | - | - | - | [1] 13 13 💬
|
| 729 | Plegridy 125 micrograms | - | - | - | - | [1] 13 13 💬
|
| 730 | Plegridy 63 micrograms | - | - | - | - | [1] 13 13 💬
|
| 731 | Plenadren 20 mg modified-release tablets | - | - | - | - | [1] 78 78 💬
|
| 732 | Plenadren 5 mg modified-release tablets | - | - | - | - | [1] 78 78 💬
|
| 733 | Pleneva TM BGC20-0134 | - | - | - | - | [1] 13 13 💬
|
| 734 | PLENUR | - | - | - | - | [1] 2 2 💬
|
| 735 | PLERIXAFOR | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [5] 20 20, 51, 65, 285, 299 💬
|
| 736 | Plerixafor for Conditioning before HSCT. | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 💬
|
| 737 | Plerixafor mobilization of autologous CD117 stem cells | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 299 299 💬
|
| 738 | PLETAL | - | - | - | - | [1] 51 51 💬
|
| 739 | PLEX | - | - | - | - | [1] 11 11 💬
|
| 740 | PLF with autograft | - | - | - | - | [1] 70 70 💬
|
| 741 | PLF with NeoFuse | - | - | - | - | [1] 70 70 💬
|
| 742 | PLL001 | - | - | - | - | [1] 2 2 💬
|
| 743 | PLN-74809 | - | - | - | - | [2] 85 85, 94 💬
|
| 744 | PLN-74809-000 | - | - | - | - | [1] 85 85 💬
|
| 745 | PLN-74809-020 | - | - | - | - | [1] 85 85 💬
|
| 746 | Plovamer acetate | [1] Acetate Acetate | - | - | - | [1] 13 13 💬
|
| 747 | Plovamer acetate 0.5 milligram (mg) | [1] Acetate Acetate | - | - | - | [1] 13 13 💬
|
| 748 | Plovamer acetate 10 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 💬
|
| 749 | Plovamer acetate 20 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 💬
|
| 750 | Plovamer acetate 3 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 💬
|
| 751 | PLP peptide | - | - | - | - | [1] 13 13 💬
|
| 752 | PLX-200 | - | - | - | - | [1] 19 19 💬
|
| 753 | PLX-PAD | [1] PLX-PAD PLX-PAD | - | - | - | [1] 86 86 💬
|
| 754 | PLX3397 | - | - | - | - | [1] 46 46 💬
|
| 755 | PLX5622 | - | - | - | - | [1] 46 46 💬
|
| 756 | Plérixafor | - | - | - | - | [1] 285 285 💬
|
| 757 | PM359 | - | - | - | - | [1] 65 65 💬
|
| 758 | PMG1015 | - | - | - | - | [1] 85 85 💬
|
| 759 | PMG1015 Dose 1 | - | - | - | - | [1] 85 85 💬
|
| 760 | PMG1015 Dose 2 | - | - | - | - | [1] 85 85 💬
|
| 761 | PMG1015 Dose 3 | - | - | - | - | [1] 85 85 💬
|
| 762 | PMG1015 Dose 4 | - | - | - | - | [1] 85 85 💬
|
| 763 | PMG1015 Dose 5 | - | - | - | - | [1] 85 85 💬
|
| 764 | PMG1015 Dose 6 | - | - | - | - | [1] 85 85 💬
|
| 765 | PMG1015 Dose 7 | - | - | - | - | [1] 85 85 💬
|
| 766 | PN 200 tablets (500 mg naproxen and 20 mg omeprazole) | [2] Naproxen Naproxen, Omeprazole | [5] Naproxen
Naproxen
,
Omeprazole
,
Naproxen sodium
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬
| [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Efferocytosis, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 💬
|
| 767 | PN-101 | - | - | - | - | [1] 50 50 💬
|
| 768 | PN-10884A | - | - | - | - | [1] 97 97 💬
|
| 769 | PN-800467 | - | - | - | - | [1] 77 77 💬
|
| 770 | PN-943 | - | - | - | - | [1] 97 97 💬
|
| 771 | PN20 | - | - | - | - | [1] 63 63 💬
|
| 772 | PN20 treatment | - | - | - | - | [1] 63 63 💬
|
| 773 | PnCJ PPS | - | - | - | - | [1] 65 65 💬
|
| 774 | Pnemovax | - | - | - | - | [1] 96 96 💬
|
| 775 | PNEUMO 23 | - | - | - | - | [2] 65 65, 97 💬
|
| 776 | Pneumo23 | - | - | - | - | [1] 107 107 💬
|
| 777 | Pneumo23 / Pneumovax | - | - | - | - | [1] 46 46 💬
|
| 778 | Pneumococcal conjugate vaccine | - | - | - | - | [1] 46 46 💬
|
| 779 | Pneumococcal Pneumonia vaccine | - | - | - | - | [1] 97 97 💬
|
| 780 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | [2] 13 13, 14 💬
|
| 781 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | [2] Aluminium Aluminium, Aluminium phosphate | [1] Aluminum phosphate
Aluminum phosphate
💬
| - | - | [1] 46 46 💬
|
| 782 | Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F | - | - | - | - | [1] 46 46 💬
|
| 783 | Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F | - | - | - | - | [1] 46 46 💬
|
| 784 | Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F | - | - | - | - | [1] 223 223 💬
|
| 785 | Pneumococcal polysaccharide serotype 11 2.2 µg | - | - | - | - | [1] 223 223 💬
|
| 786 | Pneumococcal polysaccharide vaccine | - | - | - | - | [3] 13 13, 46, 223 💬
|
| 787 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) | - | - | - | - | [1] 46 46 💬
|
| 788 | Pneumococcal polysaccharide vaccine 23 valent | - | - | - | - | [1] 265 265 💬
|
| 789 | Pneumococcal polysaccharide vaccine solution for injection in a vial | - | - | - | - | [1] 223 223 💬
|
| 790 | Pneumococcal serotypes | - | - | - | - | [1] 46 46 💬
|
| 791 | Pneumologist consult to establish the diagnosis of OHS | - | - | - | - | [1] 230 230 💬
|
| 792 | PNEUMOSTEM® | - | - | - | - | [1] 86 86 💬
|
| 793 | Pneumovax | - | - | - | - | [5] 46 46, 49, 62, 96, 223 💬
|
| 794 | PNEUMOVAX - 10 SIRINGHE PRERIEMPITE CON AGO DA 0.5 ML | - | - | - | - | [1] 62 62 💬
|
| 795 | Pneumovax 23 | - | - | - | - | [2] 46 46, 50 💬
|
| 796 | Pneumovax II | - | - | - | - | [1] 13 13 💬
|
| 797 | PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml | - | - | - | - | [2] 62 62, 66 💬
|
| 798 | Pneumovax® (pneumococcal polysaccharide vaccine) | - | - | - | - | [1] 65 65 💬
|
| 799 | PNEUMOVAX® 23 | - | - | - | - | [1] 46 46 💬
|
| 800 | PNU-215062 sodium salt | - | - | - | - | [1] 13 13 💬
|
| 801 | PO | - | - | - | - | [1] 13 13 💬
|
| 802 | PO azithromycin | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 299 299 💬
|
| 803 | PO ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 804 | POL6014 | - | - | - | - | [1] 299 299 💬
|
| 805 | POL7080 | - | - | - | - | [1] 299 299 💬
|
| 806 | Polaprezinc | [1] Polaprezinc Polaprezinc | [1] Polaprezinc
Polaprezinc
💬
| - | - | [2] 96 96, 97 💬
|
| 807 | Polidocanol | [1] Polidocanol Polidocanol | [2] Laureth 4
Laureth 4
,
Polidocanol
💬
| - | - | [3] 34 34, 278, 279 💬
|
| 808 | POLIETILENGLICOLE | - | - | - | - | [1] 97 97 💬
|
| 809 | POLISACCARIDE DELL'HAEMOPHILUS INFLUENZAE DI TIPO B CONIUGATO CON LA PROTEINA TETANICA | - | - | - | - | [1] 62 62 💬
|
| 810 | Poly ICLC | - | - | - | - | [1] 34 34 💬
|
| 811 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2- | - | - | - | - | [1] 235 235 💬
|
| 812 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI | - | - | - | - | [1] 235 235 💬
|
| 813 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBON | - | - | - | - | [1] 235 235 💬
|
| 814 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL] | - | - | - | - | [1] 235 235 💬
|
| 815 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1) | [1] Teriparatide Teriparatide | [3] Teriparatide acetate
Teriparatide acetate
,
Teriparatide
,
Teriparatide acetate
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 816 | Poly-L-D-lactic acid implant (RegJoint) interposition arthroplasty | [2] D-Lactic acid D-Lactic acid, Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [1] 46 46 💬
|
| 817 | Poly-L-lactic acid | [2] L-Lactic acid L-Lactic acid, Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [1] 265 265 💬
|
| 818 | Polyclonal IgG | - | - | - | - | [1] 65 65 💬
|
| 819 | POLYDEOXYRIBONUCLEOTIDES | - | - | - | - | [2] 51 51, 70 💬
|
| 820 | Polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [8] 6 6, 50, 96, 97, 195, 235, 276, 299 💬
|
| 821 | Polyethylene glycol (PEG) | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 97 97 💬
|
| 822 | Polyethylene Glycol 3350 | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [2] 96 96, 299 💬
|
| 823 | Polyethylene Glycols | - | - | - | - | [1] 97 97 💬
|
| 824 | PolyMVA | - | - | - | - | [1] 2 2 💬
|
| 825 | Polyphenon E | - | - | - | - | [2] 13 13, 36 💬
|
| 826 | Polyphenon E® | - | - | - | - | [1] 97 97 💬
|
| 827 | Polysomnogram | - | - | - | - | [1] 6 6 💬
|
| 828 | Polysomnography | - | - | - | - | [1] 230 230 💬
|
| 829 | Pomalidomida | - | - | - | - | [1] 51 51 💬
|
| 830 | POMALIDOMIDE | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [6] 28 28, 34, 51, 85, 227, 331 💬
|
| 831 | Pomalidomide (CC-4047 | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 832 | Pomalidomide (CC-4047) | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 💬
|
| 833 | Pomalidomide 4 MG | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 834 | Pomalidomide and Dexamethasone | [2] Dexamethasone Dexamethasone, Pomalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Pomalidomide
💬
| [3] IL6 IL6, NR3C1, TNF 💬
| [79] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 835 | Pomalidomide Oral Product | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 227 227 💬
|
| 836 | Pomegranate | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 💬
|
| 837 | PONESIMOD | [1] Ponesimod Ponesimod | [1] Ponesimod
Ponesimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 838 | Ponesimod 10 mg | [1] Ponesimod Ponesimod | [1] Ponesimod
Ponesimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 839 | Ponesimod 20 mg | [1] Ponesimod Ponesimod | [1] Ponesimod
Ponesimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 840 | Ponesimod 40 mg | [1] Ponesimod Ponesimod | [1] Ponesimod
Ponesimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 841 | PonesimodProduct Code: JNJ-67896153/ACT-128800Pharmaceutical Form: Film-coated tabletINN or Proposed INN: PonesimodCAS Number: 854107-55-4Current Sponsor code: JNJ-67896153Other descriptive name: ACT-128800Concentration unit: mg milligram(s)Concentration type: up toConcentration number: 20-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use | - | - | - | - | [1] 13 13 💬
|
| 842 | Ponticelli Regimen | - | - | - | - | [1] 222 222 💬
|
| 843 | Ponvory | - | - | - | - | [1] 13 13 💬
|
| 844 | Pooled mesenchymal stem cell | - | - | - | - | [1] 49 49 💬
|
| 845 | Pooled Plasma (Human), Solvent/Detergent Treated | - | - | - | - | [1] 64 64 💬
|
| 846 | Porcine (pig) PERT | - | - | - | - | [1] 299 299 💬
|
| 847 | Porcine PERT | - | - | - | - | [1] 299 299 💬
|
| 848 | Porphobilinogen | [1] Porphobilinogen Porphobilinogen | - | - | - | [1] 254 254 💬
|
| 849 | PORT-77 | - | - | - | - | [1] 254 254 💬
|
| 850 | Posaconazole | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [4] 60 60, 65, 96, 299 💬
|
| 851 | Posaconazole (PSZ) | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 65 65 💬
|
| 852 | Posaconazole 100 MG [Noxafil] | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 299 299 💬
|
| 853 | Posaconazole 40 MG/ML | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 299 299 💬
|
| 854 | Posaconazole Delayed Release Oral Tablet | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 96 96 💬
|
| 855 | POSACONAZOLO | - | - | - | - | [1] 299 299 💬
|
| 856 | Posiphen | [1] Posiphen Posiphen | [1] Buntanetap
Buntanetap
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 6 6 💬
|
| 857 | Positive expiratory pressure | - | - | - | - | [1] 299 299 💬
|
| 858 | Positron Emission Tomography | - | - | - | - | [6] 26 26, 28, 40, 46, 49, 96 💬
|
| 859 | Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin) | [1] Altanserin Altanserin | - | - | - | [1] 6 6 💬
|
| 860 | Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin) | [1] Altanserin Altanserin | - | - | - | [1] 6 6 💬
|
| 861 | Post-Transplant G-CSF | - | - | - | - | [3] 60 60, 62, 283 💬
|
| 862 | Posterolateral spinal fusion with instrumentation | - | - | - | - | [1] 70 70 💬
|
| 863 | Postoperative 3-month exclusive enteral nutrition | - | - | - | - | [1] 96 96 💬
|
| 864 | POTASSIO SOLFATO | - | - | - | - | [1] 97 97 💬
|
| 865 | Potassium | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [17] 36 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
|
| 866 | POTASSIUM CHLORIDE | [2] Potassium Potassium, Potassium chloride | [2] Potassium chloride
Potassium chloride
,
Potassium
💬
| - | - | [1] 97 97 💬
|
| 867 | Potassium citrate | [2] Potassium Potassium, Potassium citrate | [2] Potassium citrate
Potassium citrate
,
Potassium
💬
| - | - | [1] 223 223 💬
|
| 868 | Potassium Sparing Agents | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 57 57 💬
|
| 869 | Potassium sparing diuretic | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 235 235 💬
|
| 870 | POTASSIUM SULPHATE | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 97 97 💬
|
| 871 | Potassium supplement | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 46 46 💬
|
| 872 | Potiga | - | - | - | - | [1] 144 144 💬
|
| 873 | Povetacicept | [1] Povetacicept Povetacicept | [1] Povetacicept
Povetacicept
💬
| [1] TNFRSF13B TNFRSF13B 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | [5] 11 11, 61, 63, 66, 222 💬
|
| 874 | Povidone | [1] Povidone Povidone | [1] Povidone
Povidone
💬
| - | - | [1] 46 46 💬
|
| 875 | Povidone-iodine | [3] Iodine Iodine, Povidone, Povidone-iodine | [3] Iodine
Iodine
,
Povidone-iodine
,
Povidone
💬
| - | - | [1] 46 46 💬
|
| 876 | Powder for Oral Suspension) | - | - | - | - | [1] 113 113 💬
|
| 877 | Power doppler ultrasonography | - | - | - | - | [1] 46 46 💬
|
| 878 | PowerLung trainer | - | - | - | - | [1] 2 2 💬
|
| 879 | Pozelimab | [1] Pozelimab Pozelimab | [1] Pozelimab
Pozelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 11 11, 15, 62 💬
|
| 880 | Pozelimab + Cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab | [1] Pozelimab
Pozelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 881 | PPI treatment | - | - | - | - | [1] 299 299 💬
|
| 882 | PPS | - | - | - | - | [1] 65 65 💬
|
| 883 | Pr | - | - | - | - | [1] 41 41 💬
|
| 884 | PR Oxycodone | [1] Oxycodone Oxycodone | [3] Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 885 | PR-06410293 | - | - | - | - | [1] 46 46 💬
|
| 886 | PR006A | - | - | - | - | [1] 127 127 💬
|
| 887 | PR1 | - | - | - | - | [1] 51 51 💬
|
| 888 | PRA023 | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 889 | PRA023 IV | - | - | - | - | [1] 96 96 💬
|
| 890 | PRA023Pharmaceutical Form: Concentrate for solution for infusion | - | - | - | - | [1] 51 51 💬
|
| 891 | PRA023Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: Not yet assignedCAS Number: 2648504-55-4Current Sponsor code: PRA023Other descriptive name: PRA023Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 60-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 97 97 💬
|
| 892 | Praliciguat | [1] Praliciguat Praliciguat | [1] Praliciguat
Praliciguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 893 | Praluent | - | - | - | - | [1] 79 79 💬
|
| 894 | Praluent (Alirocumab) | [1] Alirocumab Alirocumab | [1] Alirocumab
Alirocumab
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 895 | Pramipexol | - | - | - | - | [1] 6 6 💬
|
| 896 | Pramipexol Extended Release | - | - | - | - | [1] 6 6 💬
|
| 897 | Pramipexol Immediate Release | - | - | - | - | [1] 6 6 💬
|
| 898 | Pramipexole | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [4] 2 2, 6, 20, 74 💬
|
| 899 | Pramipexole 0.125 mg tablets | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 900 | Pramipexole 0.5 mg tablets | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 901 | Pramipexole 0.6 mg | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 902 | PRAMIPEXOLE DIHYDROCHLORIDE | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 903 | Pramipexole dihydrochloride extended-release tablets | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 904 | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 905 | Pramipexole dihydrochloride monohydrate extended release | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 906 | Pramipexole ER | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 907 | Pramipexole Extended Release | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 908 | Pramipexole extended release tablet | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 909 | Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole) | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 910 | Pramipexole Immediate Release | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 911 | Pramipexole immediate release tablet | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 912 | Pramipexole IR | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 913 | Pramipexole or ropinirole | [2] Pramipexole Pramipexole, Ropinirole | [4] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Ropinirole hydrochloride
,
Pramipexole
,
Ropinirole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 914 | Pramipexole SR | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 915 | Prasinezumab | [1] Prasinezumab Prasinezumab | [1] Prasinezumab
Prasinezumab
💬
| [1] SNCA SNCA 💬
| [3] Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | [1] 6 6 💬
|
| 916 | Prasterone | [1] Prasterone Prasterone | [1] Prasterone
Prasterone
💬
| [3] AR AR, ESR1, ESR2 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 49 49 💬
|
| 917 | Prasterone (GL701) | [1] Prasterone Prasterone | [1] Prasterone
Prasterone
💬
| [3] AR AR, ESR1, ESR2 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 49 49 💬
|
| 918 | Pravastatin | [1] Pravastatin Pravastatin | [2] Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [11] 13 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
|
| 919 | Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (=14 years) | [1] Pravastatin Pravastatin | [2] Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 210 210 💬
|
| 920 | Pravastatin sodium | [1] Pravastatin Pravastatin | [2] Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 265 265 💬
|
| 921 | Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride) | [1] Pramipexole Pramipexole | [2] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 922 | PRD2175434 | - | - | - | - | [1] 113 113 💬
|
| 923 | PRD4862257 | - | - | - | - | [1] 46 46 💬
|
| 924 | PRD5973697 | - | - | - | - | [1] 97 97 💬
|
| 925 | PRD806998 | - | - | - | - | [1] 13 13 💬
|
| 926 | Pre liver transplantation laparoscopic hand assisted staging | - | - | - | - | [1] 94 94 💬
|
| 927 | Pre-filled syringe | - | - | - | - | [1] 46 46 💬
|
| 928 | Pre-filled Syringe (PFS) | - | - | - | - | [1] 46 46 💬
|
| 929 | Pre-packaged low-residue diet for bowel preparation | - | - | - | - | [1] 97 97 💬
|
| 930 | Pre-treatment with octreotide | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 931 | Prebiotic | - | - | - | - | [2] 96 96, 97 💬
|
| 932 | Prebiotic fiber blend | - | - | - | - | [1] 6 6 💬
|
| 933 | Prebiotics | - | - | - | - | [2] 96 96, 97 💬
|
| 934 | Prebiotics (Prebiotin Prebiotic Fiber Stick Pac) | - | - | - | - | [1] 13 13 💬
|
| 935 | Prebiotics and Probiotics supplementation | - | - | - | - | [1] 13 13 💬
|
| 936 | Prebiotics with galactomannan and oligofructose | - | - | - | - | [1] 193 193 💬
|
| 937 | Precedentemente denominato MEDI2070 e AMG 139 | - | - | - | - | [1] 96 96 💬
|
| 938 | PRECISION dosing Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 939 | Pred | - | - | - | - | [1] 46 46 💬
|
| 940 | Pred + Meth | - | - | - | - | [1] 46 46 💬
|
| 941 | Predinose oral | - | - | - | - | [1] 70 70 💬
|
| 942 | PredniHEXAL | - | - | - | - | [1] 46 46 💬
|
| 943 | PredniHEXAL® 10mg Tabletten | - | - | - | - | [1] 46 46 💬
|
| 944 | PredniHEXAL® 20mg Tabletten | - | - | - | - | [1] 46 46 💬
|
| 945 | PredniHEXAL® 5mg Tabletten | - | - | - | - | [1] 46 46 💬
|
| 946 | PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten | - | - | - | - | [1] 46 46 💬
|
| 947 | PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten | - | - | - | - | [1] 46 46 💬
|
| 948 | Predniso | - | - | - | - | [1] 46 46 💬
|
| 949 | Prednisolene tablets BP 1 mg | - | - | - | - | [1] 46 46 💬
|
| 950 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 951 | Prednisolon 1 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 952 | Prednisolon 10 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 953 | Prednisolon 20 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 954 | Prednisolon 5 mg JENAPHARM | - | - | - | - | [1] 41 41 💬
|
| 955 | Prednisolon 5 mg, tabletten | - | - | - | - | [2] 222 222, 223 💬
|
| 956 | Prednisolon Jenapharm | - | - | - | - | [2] 96 96, 97 💬
|
| 957 | Prednisolon Mylan 20 mg | - | - | - | - | [2] 222 222, 223 💬
|
| 958 | Prednisolon Pfizer | - | - | - | - | [2] 46 46, 50 💬
|
| 959 | Prednisolona | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 960 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 961 | Prednisolone & dipyridamole | [2] Dipyridamole Dipyridamole, Prednisolone | [2] Dipyridamole
Dipyridamole
,
Prednisolone
💬
| [3] NR3C1 NR3C1, PDE4A, PDE5A 💬
| [6] Morphine addiction Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 962 | Prednisolone + mabthera | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 61 61 💬
|
| 963 | PREDNISOLONE - prednisolone tablet | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 964 | Prednisolone 1mg Tablets | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 965 | Prednisolone 2,5 mg Tablets | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 966 | Prednisolone 20 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 967 | Prednisolone 40 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 968 | Prednisolone 5 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 💬
|
| 969 | Prednisolone 5 mg Tablets | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 970 | Prednisolone 5mg Gastro-resistant Tablets | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 971 | Prednisolone 5mg Tablet | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 972 | PREDNISOLONE ACETATE | [3] Acetate Acetate, Prednisolone, Prednisolone acetate | [2] Prednisolone
Prednisolone
,
Prednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 222 222, 223 💬
|
| 973 | Prednisolone and chlorambucil | [2] Chlorambucil Chlorambucil, Prednisolone | [2] Chlorambucil
Chlorambucil
,
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 222 222, 223 💬
|
| 974 | Prednisolone and mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Prednisolone | [3] Prednisolone
Prednisolone
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [2] 222 222, 223 💬
|
| 975 | Prednisolone and tacrolimus | [2] Prednisolone Prednisolone, Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Prednisolone
,
Tacrolimus
💬
| [6] NR3C1 NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [34] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 976 | Prednisolone and taper | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 977 | Prednisolone Labesfal | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 978 | Prednisolone plus Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisolone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisolone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 979 | Prednisolone sodium metasulphobenzoate | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 980 | PREDNISOLONE SODIUM PHOSPHATE | [2] Prednisolone Prednisolone, Prednisolone phosphate | [2] Prednisolone
Prednisolone
,
Prednisolone sodium phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 3 3, 13, 97 💬
|
| 981 | Prednisolone Sodium Phosphate Oral Solution | [2] Prednisolone Prednisolone, Prednisolone phosphate | [2] Prednisolone
Prednisolone
,
Prednisolone sodium phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 3 3 💬
|
| 982 | PREDNISOLONE SODIUM SUCCINATE | [3] Prednisolone Prednisolone, Prednisolone hemisuccinate, Succinic acid | [3] Prednisolone
Prednisolone
,
Prednisolone sodium succinate
,
Prednisolone hemisuccinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 95 95 💬
|
| 983 | Prednisolone solution 5mg/ml | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 222 222, 223 💬
|
| 984 | Prednisolone Tablets B.P. 5mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 985 | Prednisolone Tablets BP | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 986 | Prednisolone Tablets BP 1 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 987 | Prednisolone Tablets USP 5 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 988 | Prednisolone-Dipyridamole | [2] Dipyridamole Dipyridamole, Prednisolone | [2] Dipyridamole
Dipyridamole
,
Prednisolone
💬
| [3] NR3C1 NR3C1, PDE4A, PDE5A 💬
| [6] Morphine addiction Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 989 | Prednisolone/Prednisone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 990 | Prednisoloni | - | - | - | - | [1] 51 51 💬
|
| 991 | Prednisolonum | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 992 | Prednison | - | - | - | - | [4] 46 46, 84, 113, 300 💬
|
| 993 | Prednison 10 mg GALEN | - | - | - | - | [1] 35 35 💬
|
| 994 | Prednison 5 mg GALEN | - | - | - | - | [1] 35 35 💬
|
| 995 | PREDNISON 5, 20 Léciva por. tablet nob | - | - | - | - | [1] 50 50 💬
|
| 996 | Prednison 5, 20 Léciva por. tablet nob. | - | - | - | - | [1] 50 50 💬
|
| 997 | Prednison 50 mg GALEN | - | - | - | - | [1] 35 35 💬
|
| 998 | Prednison acis® 20 mg | - | - | - | - | [2] 43 43, 44 💬
|
| 999 | Prednison acis® 5 mg | - | - | - | - | [2] 43 43, 44 💬
|
| 1000 | Prednison acis¿ 20 mg | - | - | - | - | [2] 43 43, 44 💬
|
| 1001 | Prednison acis¿ 5 mg | - | - | - | - | [2] 43 43, 44 💬
|
| 1002 | Prednison20 mg GALEN | - | - | - | - | [1] 35 35 💬
|
| 1003 | PREDNISONA | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 222 💬
|
| 1004 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 1005 | Prednisone (and methylprednisolone) | [2] Methylprednisolone Methylprednisolone, Prednisone | [3] Methylprednisolone
Methylprednisolone
,
Prednisone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 💬
|
| 1006 | Prednisone (Cortancyl®) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 1007 | Prednisone (Cortancyl®) alone followed by monitoring and standard of care | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 1008 | Prednisone + Inhibace/Cozaar | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 1009 | Prednisone - Azathioprine | [2] Azathioprine Azathioprine, Prednisone | [3] Azathioprine
Azathioprine
,
Prednisone
,
Azathioprine sodium
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 11 11 💬
|
| 1010 | Prednisone 0,5 mg/kg orally on alternate days | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 222 222, 223 💬
|
| 1011 | Prednisone 1 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1012 | Prednisone 15 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1013 | Prednisone 2 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1014 | Prednisone 3 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1015 | Prednisone 30 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1016 | Prednisone 4 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1017 | Prednisone 45 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1018 | Prednisone 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 66 💬
|
| 1019 | Prednisone 5 mg tablets | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 💬
|
| 1020 | Prednisone 60 mg/meter square Body Surface Area | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1021 | Prednisone 7.5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1022 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 35 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
|
| 1023 | Prednisone Acetate Tablets | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 40 40, 224 💬
|
| 1024 | Prednisone alone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 66 💬
|
| 1025 | Prednisone and Belimumab | [2] Belimumab Belimumab, Prednisone | [2] Prednisone
Prednisone
,
Belimumab
💬
| [2] NR3C1 NR3C1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬 | [1] 300 300 💬
|
| 1026 | Prednisone and cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 1027 | Prednisone and Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Prednisone | [3] Prednisone
Prednisone
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 300 300 💬
|
| 1028 | Prednisone and ustekinumab treatment | [2] Prednisone Prednisone, Ustekinumab | [2] Prednisone
Prednisone
,
Ustekinumab
💬
| [4] IL12A IL12A, IL12B, IL23A, NR3C1 💬
| [29] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 41 41 💬
|
| 1029 | PREDNISONE ARROW 20mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 1030 | PREDNISONE ARROW 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 1031 | Prednisone Capsule | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1032 | Prednisone Capsules | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1033 | Prednisone discontinuation | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 1034 | PREDNISONE DOC GENERICI | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 1035 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 19 19 💬
|
| 1036 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 300 300 💬
|
| 1037 | Prednisone in full dose | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 1038 | Prednisone monotherapy | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 300 300 💬
|
| 1039 | Prednisone or Prednisolone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 84 💬
|
| 1040 | Prednisone Oral Product | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1041 | Prednisone plus cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 1042 | Prednisone tablet | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 1043 | PredniSONE Tablets USP, 1 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 💬
|
| 1044 | PredniSONE Tablets USP, 10 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1045 | PredniSONE Tablets USP, 1mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1046 | PredniSONE Tablets USP, 2.5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1047 | PredniSONE Tablets USP, 2.5mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1048 | PredniSONE Tablets USP, 20mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1049 | PredniSONE Tablets USP, 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 💬
|
| 1050 | PredniSONE Tablets USP, 5mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1051 | PredniSONE Tablets, USP | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 41 41, 43, 44 💬
|
| 1052 | PredniSONE Tablets, USP 10 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1053 | PredniSONE Tablets, USP 2.5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1054 | PredniSONE Tablets, USP 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1055 | PredniSONE Tablets, USP, 1 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1056 | Prednisone therapy and pharmacokinetic | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1057 | Prednisone treatment | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 1058 | Prednisone, ciclosporin and mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Prednisone | [3] Prednisone
Prednisone
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 222 222 💬
|
| 1059 | Prednisone, cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 40 40 💬
|
| 1060 | Prednisone, FK506, MMF | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1061 | Prednisone, low dose rituximab | [2] Prednisone Prednisone, Rituximab | [2] Prednisone
Prednisone
,
Rituximab
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 💬
|
| 1062 | Prednisone, methylprednisolone,cyclophosphamides | [2] Methylprednisolone Methylprednisolone, Prednisone | [3] Methylprednisolone
Methylprednisolone
,
Prednisone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
| 1063 | Prednisone,methylprednisone and cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Methylprednisone, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1064 | Prednisone/Methylprenisolone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 1065 | Prednisone/Prednisolone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 35 💬
|
| 1066 | Prednisonum micronisatum | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 85 85 💬
|
| 1067 | Prednizolon | - | - | - | - | [1] 51 51 💬
|
| 1068 | Prednizolonas | - | - | - | - | [1] 51 51 💬
|
| 1069 | Prefilled liquid etanercept(Yisaipu) | [2] Etanercept Etanercept, Yisaipu | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 1070 | Prefilled Syringe delivery of Golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1071 | Prefolic | - | - | - | - | [1] 337 337 💬
|
| 1072 | PREFOLIC 15*30CPR GASTROR 15MG | - | - | - | - | [1] 337 337 💬
|
| 1073 | PREFOLIC*30CPR GASTROR 15MG | - | - | - | - | [1] 299 299 💬
|
| 1074 | Pregabalin | [1] Pregabalin Pregabalin | [1] Pregabalin
Pregabalin
💬
| [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [5] 13 13, 36, 46, 70, 298 💬
|
| 1075 | Pregabalin 75mg | [1] Pregabalin Pregabalin | [1] Pregabalin
Pregabalin
💬
| [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 70 70 💬
|
| 1076 | Pregnancy test | - | - | - | - | [2] 50 50, 215 💬
|
| 1077 | Preimplantation factor | [1] Preimplantation factor Preimplantation factor | - | - | - | [1] 95 95 💬
|
| 1078 | Preladenant | [1] Preladenant Preladenant | [1] Preladenant
Preladenant
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1079 | Preladenant 10 mg tablet | [1] Preladenant Preladenant | [1] Preladenant
Preladenant
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1080 | Preladenant 2 mg tablet | [1] Preladenant Preladenant | [1] Preladenant
Preladenant
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1081 | Preladenant 5 mg tablet | [1] Preladenant Preladenant | [1] Preladenant
Preladenant
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1082 | Premarin and Provera | - | - | - | - | [1] 49 49 💬
|
| 1083 | Premarin ® | - | - | - | - | [1] 6 6 💬
|
| 1084 | PREOB® | - | - | - | - | [1] 71 71 💬
|
| 1085 | PREOB® cells | - | - | - | - | [1] 71 71 💬
|
| 1086 | Preoperative lanreotide treatment | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1087 | PREOTACT | - | - | - | - | [1] 235 235 💬
|
| 1088 | Preparative regimen 4-6 weeks after Leukapheresis | - | - | - | - | [1] 96 96 💬
|
| 1089 | Prepulsid | - | - | - | - | [1] 13 13 💬
|
| 1090 | Prescribe N-acetylcysteine tablets | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 90 90 💬
|
| 1091 | Prescriptive Infusion Algorithm | - | - | - | - | [1] 6 6 💬
|
| 1092 | Preservative free artificial tear gel. | - | - | - | - | [1] 157 157 💬
|
| 1093 | Preservative-free parenteral treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1094 | PREVENAR | - | - | - | - | [1] 65 65 💬
|
| 1095 | Prevenar 13 | - | - | - | - | [5] 13 13, 46, 96, 97, 223 💬
|
| 1096 | PREVENAR 13 - 0.5 ML SOSPENSION | - | - | - | - | [1] 62 62 💬
|
| 1097 | PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE | - | - | - | - | [1] 223 223 💬
|
| 1098 | Prevenar 13 sospensione per iniezione | - | - | - | - | [1] 14 14 💬
|
| 1099 | Prevenar 13 suspension for injection | - | - | - | - | [1] 223 223 💬
|
| 1100 | Prevenar vaccination | - | - | - | - | [1] 46 46 💬
|
| 1101 | Prevenar vaccine | - | - | - | - | [1] 46 46 💬
|
| 1102 | Prevenar13 | - | - | - | - | [3] 19 19, 79, 265 💬
|
| 1103 | Prevenar® (7-valent pneumococcal conjugate vaccine) | - | - | - | - | [1] 65 65 💬
|
| 1104 | Prevenar® and Pneumo23® | - | - | - | - | [1] 49 49 💬
|
| 1105 | Preventative (Prophylactic) Medication - Corticosteroids: Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 1106 | Prevention of ferret airway basal cell transplantation | - | - | - | - | [1] 228 228 💬
|
| 1107 | Previously known as R935788 | - | - | - | - | [1] 46 46 💬
|
| 1108 | Previously referred to as MEDI2070 and AMG 139 | - | - | - | - | [2] 96 96, 97 💬
|
| 1109 | Previously referred to as MEDI2070 and AMG 139, AGN-151-598 | - | - | - | - | [1] 96 96 💬
|
| 1110 | Previously termed sc.AAV9.CB.SMN and AVXS-101 | - | - | - | - | [1] 3 3 💬
|
| 1111 | PRG-1801 | - | - | - | - | [2] 63 63, 300 💬
|
| 1112 | PRG-2311 | - | - | - | - | [1] 300 300 💬
|
| 1113 | PrGCD | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 1114 | Pridia (Donepezil Hydrochloride) 5mg | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 6 6 💬
|
| 1115 | Pridia 10mg | - | - | - | - | [1] 6 6 💬
|
| 1116 | Pridia 5mg | - | - | - | - | [1] 6 6 💬
|
| 1117 | Pridiopidine | - | - | - | - | [1] 8 8 💬
|
| 1118 | Pridopidina | - | - | - | - | [1] 8 8 💬
|
| 1119 | Pridopidine | [1] Pridopidine Pridopidine | [2] Pridopidine
Pridopidine
,
Pridopidine hydrochloride
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3] 2 2, 6, 8 💬
|
| 1120 | Pridopidine (90 mg) | [1] Pridopidine Pridopidine | [2] Pridopidine
Pridopidine
,
Pridopidine hydrochloride
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 1121 | PRIDOPIDINE HYDROCHLORIDE | [1] Pridopidine Pridopidine | [2] Pridopidine
Pridopidine
,
Pridopidine hydrochloride
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 1122 | PRIM-DJ2727 | - | - | - | - | [3] 6 6, 51, 97 💬
|
| 1123 | PRIM-DJ2727 - CAPSULES | - | - | - | - | [1] 97 97 💬
|
| 1124 | PRIM-DJ2727 - FROZEN | - | - | - | - | [1] 97 97 💬
|
| 1125 | Primary Cervical Dystonia (Trihexyphenidyl) | [1] Trihexyphenidyl Trihexyphenidyl | [2] Trihexyphenidyl hydrochloride
Trihexyphenidyl hydrochloride
,
Trihexyphenidyl
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1126 | Primavanserin tartrate | - | - | - | - | [1] 6 6 💬
|
| 1127 | PrimeC | - | - | - | - | [1] 2 2 💬
|
| 1128 | Primidone | [1] Primidone Primidone | [1] Primidone
Primidone
💬
| - | - | [2] 2 2, 113 💬
|
| 1129 | Primus FGTI (Flexible Great toe Implant) | - | - | - | - | [1] 46 46 💬
|
| 1130 | Prior Donepezil 5mg | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 6 6 💬
|
| 1131 | Prior Donzepezil 10mg | - | - | - | - | [1] 6 6 💬
|
| 1132 | PRIVIGEN | - | - | - | - | [6] 11 11, 14, 51, 63, 65, 222 💬
|
| 1133 | PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML | - | - | - | - | [1] 51 51 💬
|
| 1134 | Privigen 100 mg/ml solution pour perfusion | - | - | - | - | [1] 222 222 💬
|
| 1135 | Privigen 100 mg/ml, solution pour perfusion | - | - | - | - | [1] 53 53 💬
|
| 1136 | PRIVIGEN 100mg/ml | - | - | - | - | [1] 85 85 💬
|
| 1137 | Privigen® | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 1138 | Privigen® 100mg/ml at the dose of 2g/kg of body weight | - | - | - | - | [1] 53 53 💬
|
| 1139 | PRM-151 | - | - | - | - | [1] 85 85 💬
|
| 1140 | PRM-151 (Zinpentraxin Alfa) | [1] Zinpentraxin alfa Zinpentraxin alfa | [1] Zinpentraxin alfa
Zinpentraxin alfa
💬
| - | - | [1] 85 85 💬
|
| 1141 | PRN1008 | - | - | - | - | [4] 35 35, 61, 63, 300 💬
|
| 1142 | PRN1008 (Rilzabrutinib) | [1] Rilzabrutinib Rilzabrutinib | [1] Rilzabrutinib
Rilzabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 35 35 💬
|
| 1143 | PRN1008 100 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 1144 | PRN1008 300 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 1145 | PRN1008 400 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 1146 | PRN1008 Freebase | - | - | - | - | [1] 35 35 💬
|
| 1147 | PRN2246 | - | - | - | - | [2] 11 11, 13 💬
|
| 1148 | PRO-203 | - | - | - | - | [1] 51 51 💬
|
| 1149 | PRO044 | - | - | - | - | [1] 113 113 💬
|
| 1150 | PRO044 IV | - | - | - | - | [1] 113 113 💬
|
| 1151 | PRO044 IV 6 mg/kg | - | - | - | - | [1] 113 113 💬
|
| 1152 | PRO044 IV 9 mg/kg | - | - | - | - | [1] 113 113 💬
|
| 1153 | PRO044 SC | - | - | - | - | [1] 113 113 💬
|
| 1154 | PRO044 SC 6 mg/kg | - | - | - | - | [1] 113 113 💬
|
| 1155 | PRO045 | - | - | - | - | [1] 113 113 💬
|
| 1156 | PRO045, 0.15 mg/kg/week | - | - | - | - | [1] 113 113 💬
|
| 1157 | PRO045, 1.0 mg/kg/week | - | - | - | - | [1] 113 113 💬
|
| 1158 | PRO045, 3.0 mg/kg/week | - | - | - | - | [1] 113 113 💬
|
| 1159 | PRO045, 6.0 mg/kg/week | - | - | - | - | [1] 113 113 💬
|
| 1160 | PRO045, 9.0 mg/kg/week | - | - | - | - | [1] 113 113 💬
|
| 1161 | PRO045, selected dose | - | - | - | - | [1] 113 113 💬
|
| 1162 | PRO051 | - | - | - | - | [1] 113 113 💬
|
| 1163 | PRO053 | - | - | - | - | [1] 113 113 💬
|
| 1164 | PRO145223 | - | - | - | - | [1] 97 97 💬
|
| 1165 | PRO145223 (RO5490261) | - | - | - | - | [1] 97 97 💬
|
| 1166 | PRO283698 | - | - | - | - | [1] 46 46 💬
|
| 1167 | Probenecid | [1] Probenecid Probenecid | [1] Probenecid
Probenecid
💬
| - | - | [1] 25 25 💬
|
| 1168 | Probiotic | - | - | - | - | [10] 2 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
|
| 1169 | Probiotic - VSL#3 | - | - | - | - | [2] 96 96, 97 💬
|
| 1170 | Probiotic Agent | - | - | - | - | [1] 63 63 💬
|
| 1171 | Probiotic Capsule | - | - | - | - | [1] 6 6 💬
|
| 1172 | Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 | - | - | - | - | [1] 46 46 💬
|
| 1173 | Probiotic dietary supplement | - | - | - | - | [1] 13 13 💬
|
| 1174 | Probiotic Formula Capsule | - | - | - | - | [1] 97 97 💬
|
| 1175 | Probiotic group | - | - | - | - | [1] 271 271 💬
|
| 1176 | Probiotic K10 | - | - | - | - | [1] 6 6 💬
|
| 1177 | Probiotic Mixture | - | - | - | - | [2] 96 96, 97 💬
|
| 1178 | Probiotic Product - Cap | - | - | - | - | [1] 53 53 💬
|
| 1179 | Probiotic supplement | - | - | - | - | [1] 6 6 💬
|
| 1180 | Probiotic throat spray | - | - | - | - | [1] 299 299 💬
|
| 1181 | Probiotic treatment | - | - | - | - | [1] 294 294 💬
|
| 1182 | Probiotic-Lactobacillus plantarum PS128 | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [1] 156 156 💬
|
| 1183 | Probiotics | - | - | - | - | [6] 6 6, 94, 96, 97, 206, 291 💬
|
| 1184 | Probiotics (Bacillus Clausii) | [1] Bacillus clausii Bacillus clausii | - | - | - | [1] 97 97 💬
|
| 1185 | Probiotics (Visbiome®) | - | - | - | - | [1] 13 13 💬
|
| 1186 | Probiotics 6600 | - | - | - | - | [1] 97 97 💬
|
| 1187 | Probiotics combined with enteric-coated budesonide capsule | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 1188 | Probiotics including B. lactis B420, B. lactis HN019, B. animalis Bb-12, L. rhamnosus GG | - | - | - | - | [1] 193 193 💬
|
| 1189 | Probiotics with prebiotic | - | - | - | - | [1] 6 6 💬
|
| 1190 | Probucol | [1] Probucol Probucol | [1] Probucol
Probucol
💬
| - | - | [4] 21 21, 66, 79, 223 💬
|
| 1191 | Procalcitonin | [1] Procalcitonin Procalcitonin | - | - | - | [3] 43 43, 44, 299 💬
|
| 1192 | Procaptan | - | - | - | - | [1] 58 58 💬
|
| 1193 | PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | [1] 58 58 💬
|
| 1194 | PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | [1] 58 58 💬
|
| 1195 | Procarbazine | [1] Procarbazine Procarbazine | [2] Procarbazine hydrochloride
Procarbazine hydrochloride
,
Procarbazine
💬
| - | - | [1] 65 65 💬
|
| 1196 | Procedure/Surgery: Implant Procedure | - | - | - | - | [1] 13 13 💬
|
| 1197 | Procedure: endoscopic biopsy | - | - | - | - | [1] 97 97 💬
|
| 1198 | PROCHYMAL (remestemcel-L) | [1] Remestemcel-L Remestemcel-L | [1] Remestemcel-L
Remestemcel-L
💬
| - | - | [1] 96 96 💬
|
| 1199 | PROCHYMAL adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 1200 | Prochymal® | - | - | - | - | [1] 96 96 💬
|
| 1201 | Prochymal™ adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 1202 | PROCORALAN | - | - | - | - | [1] 57 57 💬
|
| 1203 | PROCYSBI | - | - | - | - | [1] 19 19 💬
|
| 1204 | Prodarsan | - | - | - | - | [1] 192 192 💬
|
| 1205 | Products containing aminosalicylate | - | - | - | - | [1] 97 97 💬
|
| 1206 | Products containing azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 97 97 💬
|
| 1207 | Profilassi per Herpes Zoster | - | - | - | - | [1] 107 107 💬
|
| 1208 | Progerinin | [1] Progerinin Progerinin | [1] Progerinin
Progerinin
💬
| - | - | [2] 191 191, 333 💬
|
| 1209 | Progesterone | [1] Progesterone Progesterone | [1] Progesterone
Progesterone
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [2] 76 76, 299 💬
|
| 1210 | Proglumide | [1] Proglumide Proglumide | [1] Proglumide
Proglumide
💬
| [1] CCKBR CCKBR 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 298 298 💬
|
| 1211 | Prograf | - | - | - | - | [3] 60 60, 222, 226 💬
|
| 1212 | Prograff (tacrolimus) | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 222 222, 223 💬
|
| 1213 | Prograft capsules | - | - | - | - | [1] 299 299 💬
|
| 1214 | Progranulin | [1] Progranulin Progranulin | - | - | - | [1] 127 127 💬
|
| 1215 | Progressive spacing of TNF-blocker injections | - | - | - | - | [1] 46 46 💬
|
| 1216 | Progynova 21 mite | - | - | - | - | [1] 65 65 💬
|
| 1217 | Prohance (Gadoteridol) | [1] Gadoteridol Gadoteridol | [1] Gadoteridol
Gadoteridol
💬
| - | - | [1] 13 13 💬
|
| 1218 | Prolastin | - | - | - | - | [1] 231 231 💬
|
| 1219 | Prolastin (drug) | - | - | - | - | [1] 299 299 💬
|
| 1220 | Prolastin-C | - | - | - | - | [2] 231 231, 298 💬
|
| 1221 | Prolastin-C, 120 mg/kg | - | - | - | - | [1] 231 231 💬
|
| 1222 | Prolastin-C, 60 mg/kg | - | - | - | - | [1] 231 231 💬
|
| 1223 | Proleukin | - | - | - | - | [2] 2 2, 49 💬
|
| 1224 | Proleukin 18 MUI | - | - | - | - | [1] 2 2 💬
|
| 1225 | Proleukin® | - | - | - | - | [1] 222 222 💬
|
| 1226 | PROLEUKIN® S | - | - | - | - | [1] 65 65 💬
|
| 1227 | Prolia | - | - | - | - | [1] 274 274 💬
|
| 1228 | Prolife | - | - | - | - | [1] 97 97 💬
|
| 1229 | Proline | [1] Proline Proline | [1] Proline
Proline
💬
| - | - | [3] 66 66, 94, 97 💬
|
| 1230 | Prolonged release tablet | - | - | - | - | [1] 6 6 💬
|
| 1231 | Prolonged-release Fampridine | - | - | - | - | [1] 13 13 💬
|
| 1232 | Prolopa® | - | - | - | - | [1] 6 6 💬
|
| 1233 | Prolotherapy solution of 20% dextrose | - | - | - | - | [1] 70 70 💬
|
| 1234 | Promacta | - | - | - | - | [1] 65 65 💬
|
| 1235 | Promestriene | [1] Promestriene Promestriene | [1] Promestriene
Promestriene
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 53 53 💬
|
| 1236 | Promestriene Vaginal | [1] Promestriene Promestriene | [1] Promestriene
Promestriene
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 53 53 💬
|
| 1237 | Promethazine | [1] Promethazine Promethazine | [3] Promethazine hydrochloride
Promethazine hydrochloride
,
Promethazine
,
Promethazine teoclate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 6 6, 96 💬
|
| 1238 | Promethera HepaStem | - | - | - | - | [1] 251 251 💬
|
| 1239 | Prometic's Immune Globulin Intravenous 10% | - | - | - | - | [1] 65 65 💬
|
| 1240 | Promiten | - | - | - | - | [1] 97 97 💬
|
| 1241 | Promixin | - | - | - | - | [1] 299 299 💬
|
| 1242 | Promixin 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 💬
|
| 1243 | PROMIXIN*NEBUL 30MONOD 1MUI | - | - | - | - | [1] 299 299 💬
|
| 1244 | Promixin, 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 💬
|
| 1245 | Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador | - | - | - | - | [1] 299 299 💬
|
| 1246 | Promixin/Tadim | - | - | - | - | [1] 299 299 💬
|
| 1247 | Propanoic acid | [1] Propanoic acid Propanoic acid | [3] Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | [2] 6 6, 271 💬
|
| 1248 | Propanolol | - | - | - | - | [1] 296 296 💬
|
| 1249 | Propantheline | [1] Propantheline Propantheline | [1] Propantheline bromide
Propantheline bromide
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 26 26 💬
|
| 1250 | Propantheline Bromide | [1] Propantheline Propantheline | [1] Propantheline bromide
Propantheline bromide
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 26 26 💬
|
| 1251 | Prophylactic Corticosteroid Taper Regimen | - | - | - | - | [1] 251 251 💬
|
| 1252 | Prophylactic Immunomodulatory (IM) Therapy | - | - | - | - | [1] 19 19 💬
|
| 1253 | Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor | [2] Cefaclor Cefaclor, Sulfamethoxazole | [3] Cefaclor
Cefaclor
,
Sulfamethoxazole
,
Cefaclor
💬
| - | - | [1] 296 296 💬
|
| 1254 | Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal) | - | - | - | - | [1] 13 13 💬
|
| 1255 | Propionic acid 1000 mg capsule | - | - | - | - | [1] 13 13 💬
|
| 1256 | PROPIONYL L-CARNITINE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1257 | PROPIONYL L-CARNITINE HYDROCHLORIDE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1258 | Propionyl-L-Carnitine | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1259 | Propionylcarnitinhydrochlorid | - | - | - | - | [1] 97 97 💬
|
| 1260 | Propiverine | [1] Propiverine Propiverine | [2] Propiverine hydrochloride
Propiverine hydrochloride
,
Propiverine
💬
| [9] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [44] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
| 1261 | Propiverine Hydrochloride | [1] Propiverine Propiverine | [2] Propiverine hydrochloride
Propiverine hydrochloride
,
Propiverine
💬
| [9] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [44] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
| 1262 | Propofol | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [10] 3 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
|
| 1263 | Propofol B. Braun | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1264 | Propofol Injection | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 70 70 💬
|
| 1265 | Propofol-Lipuro | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 6 6 💬
|
| 1266 | Propolipid | - | - | - | - | [1] 46 46 💬
|
| 1267 | Proposed INN - FILGOTINIB | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬
|
| 1268 | Propranolol | [1] Propranolol Propranolol | [2] Propranolol hydrochloride
Propranolol hydrochloride
,
Propranolol
💬
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬
| [14] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 6 6, 158, 167, 215, 216, 227, 278 💬
|
| 1269 | Propranolol HCl CF 40 mg tablet | [1] Propranolol Propranolol | [2] Propranolol hydrochloride
Propranolol hydrochloride
,
Propranolol
💬
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬
| [14] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1270 | Propranolol Hydrochloride | [1] Propranolol Propranolol | [2] Propranolol hydrochloride
Propranolol hydrochloride
,
Propranolol
💬
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬
| [14] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 215 215, 216 💬
|
| 1271 | Propranolol treatment | [1] Propranolol Propranolol | [2] Propranolol hydrochloride
Propranolol hydrochloride
,
Propranolol
💬
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬
| [14] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 227 227 💬
|
| 1272 | Propsoed INN - FILGOTINIB | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬
|
| 1273 | Propylene glycol | [1] Propylene glycol Propylene glycol | [2] Propylene glycol
Propylene glycol
,
Propylene glycol diacetate
💬
| - | - | [2] 28 28, 51 💬
|
| 1274 | Propylene Glycol-Free Melphalan Hydrochloride | [2] Melphalan Melphalan, Propylene glycol | [4] Propylene glycol
Propylene glycol
,
Melphalan
,
Propylene glycol diacetate
,
Melphalan hydrochloride
💬
| - | - | [1] 28 28 💬
|
| 1275 | ProSavin | - | - | - | - | [1] 6 6 💬
|
| 1276 | PROSCAR*30CPR RIV 5MG | - | - | - | - | [1] 6 6 💬
|
| 1277 | Prosetin | [1] Prosetin Prosetin | - | - | - | [1] 2 2 💬
|
| 1278 | Prostacyclin | - | - | - | - | [1] 86 86 💬
|
| 1279 | Prostacyclin Receptor Agonist | - | - | - | - | [1] 86 86 💬
|
| 1280 | Prostanoids | - | - | - | - | [1] 51 51 💬
|
| 1281 | Protandim | - | - | - | - | [1] 2 2 💬
|
| 1282 | PROTEASA | - | - | - | - | [1] 299 299 💬
|
| 1283 | PROTEASE | - | - | - | - | [1] 299 299 💬
|
| 1284 | Protease inhibitor | - | - | - | - | [1] 265 265 💬
|
| 1285 | Protease inhibitors | - | - | - | - | [1] 265 265 💬
|
| 1286 | ProTectis | - | - | - | - | [1] 66 66 💬
|
| 1287 | Protein | - | - | - | - | [3] 46 46, 67, 240 💬
|
| 1288 | Protein A immunoadsorption | - | - | - | - | [1] 13 13 💬
|
| 1289 | Protein convertase subtilisin/kexin type 9 inhibitor | - | - | - | - | [1] 79 79 💬
|
| 1290 | Protein hydrolysate | [1] Protein hydrolysate Protein hydrolysate | [1] Protein hydrolysate
Protein hydrolysate
💬
| - | - | [1] 97 97 💬
|
| 1291 | Protein intake | - | - | - | - | [1] 240 240 💬
|
| 1292 | Protein-carbohydrate supplementation | - | - | - | - | [1] 113 113 💬
|
| 1293 | Proteolytic enzyme fortified protein supplement | - | - | - | - | [1] 298 298 💬
|
| 1294 | Proteína recombinante estimulante de la megacariopoyesis | - | - | - | - | [1] 63 63 💬
|
| 1295 | Prothrombin | [1] Prothrombin Prothrombin | - | - | - | [2] 35 35, 288 💬
|
| 1296 | Prothrombin Complex Concentrate | [1] Prothrombin Prothrombin | - | - | - | [1] 288 288 💬
|
| 1297 | Proton pump inhibitor (PPI) | - | - | - | - | [1] 298 298 💬
|
| 1298 | Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month | - | - | - | - | [1] 63 63 💬
|
| 1299 | Prototype capsule GDC-0134 | [1] GDC-0134 GDC-0134 | - | - | - | [1] 2 2 💬
|
| 1300 | Provigil | - | - | - | - | [1] 13 13 💬
|
| 1301 | Provigil (modafinil) | [1] Modafinil Modafinil | [1] Modafinil
Modafinil
💬
| - | - | [1] 13 13 💬
|
| 1302 | PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE | - | - | - | - | [1] 113 113 💬
|
| 1303 | Proximod | - | - | - | - | [1] 46 46 💬
|
| 1304 | Proximod 10mg daily | - | - | - | - | [1] 46 46 💬
|
| 1305 | Proximod 5mg daily | - | - | - | - | [1] 46 46 💬
|
| 1306 | PROZAC | - | - | - | - | [1] 17 17 💬
|
| 1307 | PRP | - | - | - | - | [1] 90 90 💬
|
| 1308 | PRP and PBD-VSEL Stem Cell therapy | - | - | - | - | [1] 6 6 💬
|
| 1309 | PRP injection | - | - | - | - | [1] 53 53 💬
|
| 1310 | PrP-siRNA | - | - | - | - | [1] 23 23 💬
|
| 1311 | PRTX-100 | [1] PRTX-100 PRTX-100 | - | - | - | [2] 46 46, 63 💬
|
| 1312 | PRTX-100 (Staphylococcal protein A) | [1] PRTX-100 PRTX-100 | - | - | - | [1] 63 63 💬
|
| 1313 | PRTX-100 at 1.5 mcg/kg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1314 | PRTX-100 at 12.0 mcg/kg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1315 | PRTX-100 at 240 mcg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1316 | PRTX-100 at 3.0 mcg/kg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1317 | PRTX-100 at 420 mcg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1318 | PRTX-100 at 6.0 mcg/kg | [1] PRTX-100 PRTX-100 | - | - | - | [1] 46 46 💬
|
| 1319 | PRU-PLA-PLA-PRU | - | - | - | - | [1] 99 99 💬
|
| 1320 | PRU-PLA-PRU-PLA | - | - | - | - | [1] 99 99 💬
|
| 1321 | PRUCALOPRIDE | [1] Prucalopride Prucalopride | [2] Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [3] 13 13, 51, 96 💬
|
| 1322 | PRUCALOPRIDE SUCCINATE | [1] Prucalopride Prucalopride | [2] Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 1323 | PRV-300 | - | - | - | - | [1] 97 97 💬
|
| 1324 | PRV-3279 | - | - | - | - | [1] 49 49 💬
|
| 1325 | PRV-6527 | - | - | - | - | [1] 96 96 💬
|
| 1326 | PRV-6527 (JNJ-40346527) | - | - | - | - | [1] 96 96 💬
|
| 1327 | PRV-6527(JNJ-40346527) | - | - | - | - | [1] 96 96 💬
|
| 1328 | PRX-102 | - | - | - | - | [1] 19 19 💬
|
| 1329 | PRX-102 (pegunigalsidase alfa) | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 1330 | PRX-102 1 mg/kg every 2 weeks | - | - | - | - | [1] 19 19 💬
|
| 1331 | PRX-102 1 mg/kg every two weeks | - | - | - | - | [1] 19 19 💬
|
| 1332 | PRX-102 2 mg/kg every 4 weeks | - | - | - | - | [1] 19 19 💬
|
| 1333 | PRX-112 | - | - | - | - | [1] 19 19 💬
|
| 1334 | PRX002 | - | - | - | - | [1] 6 6 💬
|
| 1335 | PRX002, ELT2, anti-alpha-synuclein monoclonal antibody | - | - | - | - | [1] 6 6 💬
|
| 1336 | PRX102 | - | - | - | - | [1] 19 19 💬
|
| 1337 | PS128 | - | - | - | - | [1] 6 6 💬
|
| 1338 | PS188 | - | - | - | - | [1] 113 113 💬
|
| 1339 | PS188 (company code) | - | - | - | - | [1] 113 113 💬
|
| 1340 | PS220 | - | - | - | - | [1] 113 113 💬
|
| 1341 | PS524 | - | - | - | - | [1] 113 113 💬
|
| 1342 | PS659 | - | - | - | - | [2] 8 8, 18 💬
|
| 1343 | PsAer IgY | - | - | - | - | [1] 299 299 💬
|
| 1344 | Pseudoephedrine | [1] Pseudoephedrine Pseudoephedrine | [4] Pseudoephedrine hydrochloride
Pseudoephedrine hydrochloride
,
Pseudoephedrine polistirex
,
Pseudoephedrine sulfate
,
Pseudoephedrine
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 💬
|
| 1345 | Pseudoephedrine + 480 ml water | [2] Pseudoephedrine Pseudoephedrine, Water | [5] Water
Water
,
Pseudoephedrine hydrochloride
,
Pseudoephedrine polistirex
,
Pseudoephedrine sulfate
,
Pseudoephedrine
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 💬
|
| 1346 | Pseudoephedrine + 50 ml water | [2] Pseudoephedrine Pseudoephedrine, Water | [5] Water
Water
,
Pseudoephedrine hydrochloride
,
Pseudoephedrine polistirex
,
Pseudoephedrine sulfate
,
Pseudoephedrine
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 💬
|
| 1347 | Psilocybin | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [5] 2 2, 6, 13, 149, 206 💬
|
| 1348 | Psilocybin (drug) | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 1349 | Psilocybin (Usona Institute) | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 149 149 💬
|
| 1350 | Psilocybin therapy | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [3] 2 2, 6, 13 💬
|
| 1351 | Psilocybin, 1.5 mg | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 206 206 💬
|
| 1352 | Psilocybine | [1] Psilocybin Psilocybin | [1] Psilocybin
Psilocybin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 1353 | Psorcutan-Ointment | - | - | - | - | [1] 36 36 💬
|
| 1354 | PSRS11.EFS.IL2RG.pre* retroviral vector | - | - | - | - | [1] 65 65 💬
|
| 1355 | PSRS11.EFS.IL2RG.pre* retroviral vector transduce | - | - | - | - | [1] 65 65 💬
|
| 1356 | PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells | - | - | - | - | [1] 65 65 💬
|
| 1357 | Psyllium | - | - | - | - | [2] 6 6, 28 💬
|
| 1358 | Psyllium Husk Powder | - | - | - | - | [1] 97 97 💬
|
| 1359 | PT320 2.0 mg | - | - | - | - | [1] 6 6 💬
|
| 1360 | PT320 2.5 mg | - | - | - | - | [1] 6 6 💬
|
| 1361 | PTC-0161480 | - | - | - | - | [2] 246 246, 299 💬
|
| 1362 | PTC-124 | - | - | - | - | [2] 246 246, 299 💬
|
| 1363 | PTC-C124 | - | - | - | - | [2] 246 246, 299 💬
|
| 1364 | PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844 | - | - | - | - | [1] 113 113 💬
|
| 1365 | PTC124 | - | - | - | - | [4] 19 19, 113, 246, 299 💬
|
| 1366 | PTC299 | - | - | - | - | [1] 34 34 💬
|
| 1367 | PTC518 | - | - | - | - | [1] 8 8 💬
|
| 1368 | PTC518 tablet 20 mg | - | - | - | - | [1] 8 8 💬
|
| 1369 | PTC518 tablet 5 mg | - | - | - | - | [1] 8 8 💬
|
| 1370 | PTC743 | - | - | - | - | [2] 18 18, 21 💬
|
| 1371 | PTC857 | - | - | - | - | [1] 2 2 💬
|
| 1372 | PTC857 60 mg/mL oral solution | - | - | - | - | [1] 2 2 💬
|
| 1373 | PTC857 oral solution | - | - | - | - | [1] 2 2 💬
|
| 1374 | PTC923 | - | - | - | - | [1] 240 240 💬
|
| 1375 | Pterostilbene | [1] Pterostilbene Pterostilbene | - | - | - | [1] 2 2 💬
|
| 1376 | PTG-100 | - | - | - | - | [1] 97 97 💬
|
| 1377 | PTG-200 | - | - | - | - | [1] 96 96 💬
|
| 1378 | PTH | - | - | - | - | [1] 235 235 💬
|
| 1379 | PTH 1-34 | - | - | - | - | [2] 65 65, 235 💬
|
| 1380 | PTH1-84 in parent study | - | - | - | - | [1] 235 235 💬
|
| 1381 | PTI-428 | - | - | - | - | [1] 299 299 💬
|
| 1382 | PTI-801 | [1] PTI-801 PTI-801 | - | - | - | [1] 299 299 💬
|
| 1383 | PTI-808 | - | - | - | - | [1] 299 299 💬
|
| 1384 | PTL201 | - | - | - | - | [1] 13 13 💬
|
| 1385 | PTOC1 | - | - | - | - | [1] 49 49 💬
|
| 1386 | PTR-01 | [1] PTR-01 PTR-01 | - | - | - | [1] 36 36 💬
|
| 1387 | PTW-002 10 mg/g gel | - | - | - | - | [1] 36 36 💬
|
| 1388 | PTX-022 | - | - | - | - | [1] 278 278 💬
|
| 1389 | PU-AD | - | - | - | - | [1] 2 2 💬
|
| 1390 | Puerarin | [1] Puerarin Puerarin | - | - | - | [1] 46 46 💬
|
| 1391 | Puerarin injection 400 mg | [1] Puerarin Puerarin | - | - | - | [1] 46 46 💬
|
| 1392 | Puerarin tablet 50 mg | [1] Puerarin Puerarin | - | - | - | [1] 46 46 💬
|
| 1393 | PUFA muffin | - | - | - | - | [1] 79 79 💬
|
| 1394 | Pulmaquin® | - | - | - | - | [1] 299 299 💬
|
| 1395 | Pulmonary endarterectomy | - | - | - | - | [1] 88 88 💬
|
| 1396 | Pulmonary Endarteriectomy | - | - | - | - | [1] 88 88 💬
|
| 1397 | Pulmonary Function Testing | - | - | - | - | [4] 2 2, 228, 299, 340 💬
|
| 1398 | Pulmonary function testing. | - | - | - | - | [2] 231 231, 299 💬
|
| 1399 | Pulmonary hypertension (PH)-specific medication | - | - | - | - | [1] 88 88 💬
|
| 1400 | Pulmonary hypertension-specific therapy | - | - | - | - | [1] 88 88 💬
|
| 1401 | Pulmozyme | - | - | - | - | [1] 299 299 💬
|
| 1402 | Pulmozyme (dornase alfa) | [1] Dornase alfa Dornase alfa | [1] Dornase alfa
Dornase alfa
💬
| - | - | [1] 299 299 💬
|
| 1403 | Pulmozyme (Dornase alpha) | - | - | - | - | [1] 299 299 💬
|
| 1404 | Pulmozyme single use ampule | - | - | - | - | [1] 299 299 💬
|
| 1405 | Pulmozyme® | - | - | - | - | [1] 299 299 💬
|
| 1406 | PUR 0110 | - | - | - | - | [1] 97 97 💬
|
| 1407 | PUR 0110 Rectal Enema | - | - | - | - | [1] 97 97 💬
|
| 1408 | PUR 0110 Rectal Enema 1000 mg | - | - | - | - | [1] 97 97 💬
|
| 1409 | PUR 0110 Rectal Enema 250 mg | - | - | - | - | [1] 97 97 💬
|
| 1410 | PUR 0110 Rectal Enema 500 mg | - | - | - | - | [1] 97 97 💬
|
| 1411 | PUR118 | - | - | - | - | [1] 299 299 💬
|
| 1412 | Pure give pectin 20g/d for five days | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [1] 97 97 💬
|
| 1413 | Puri Nethol | - | - | - | - | [2] 96 96, 97 💬
|
| 1414 | Puri-Nethol | - | - | - | - | [3] 86 86, 96, 97 💬
|
| 1415 | Puri-Nethol 50 mg | - | - | - | - | [1] 96 96 💬
|
| 1416 | Purified form of the lysosomal enzyme iduronate-2-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 1417 | Purified Vero Cell Vaccine) | - | - | - | - | [1] 65 65 💬
|
| 1418 | PURINETHOL | - | - | - | - | [1] 96 96 💬
|
| 1419 | PURINETHOL - 50 MG COMPRESSE25 COMPRESSE | - | - | - | - | [1] 96 96 💬
|
| 1420 | PVT201 | - | - | - | - | [1] 93 93 💬
|
| 1421 | PVT401 | - | - | - | - | [1] 97 97 💬
|
| 1422 | PXL065 | - | - | - | - | [1] 20 20 💬
|
| 1423 | PXL770 | - | - | - | - | [1] 20 20 💬
|
| 1424 | PXT002331 | - | - | - | - | [1] 6 6 💬
|
| 1425 | PXT002331 - 20mg | - | - | - | - | [1] 6 6 💬
|
| 1426 | PXT002331 - dose 1 | - | - | - | - | [1] 6 6 💬
|
| 1427 | PXT002331 - dose 2 | - | - | - | - | [1] 6 6 💬
|
| 1428 | PXT3003 | - | - | - | - | [1] 10 10 💬
|
| 1429 | PXT3003 Dose 1 | - | - | - | - | [1] 10 10 💬
|
| 1430 | PXT3003 Dose 2 | - | - | - | - | [1] 10 10 💬
|
| 1431 | PXT3003 Dose 2 (equivalent to twice Dose 1) | - | - | - | - | [1] 10 10 💬
|
| 1432 | PXT3003 High Dose | - | - | - | - | [1] 10 10 💬
|
| 1433 | PXT3003 Intermediate Dose | - | - | - | - | [1] 10 10 💬
|
| 1434 | PXT3003 Low dose | - | - | - | - | [1] 10 10 💬
|
| 1435 | PYC-003 | - | - | - | - | [1] 67 67 💬
|
| 1436 | PYM50028 | - | - | - | - | [1] 6 6 💬
|
| 1437 | Pyrazole | [1] Pyrazole Pyrazole | - | - | - | [1] 58 58 💬
|
| 1438 | Pyridostigmine | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 1439 | Pyridostigmine Bromide | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 1440 | Pyridostigmine, Prednisone, Tacrolimus | [3] Prednisone Prednisone, Pyridostigmine, Tacrolimus | [4] Tacrolimus
Tacrolimus
,
Prednisone
,
Pyridostigmine bromide
,
Tacrolimus
💬
| [7] ACHE ACHE, NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [37] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 1441 | Pyridostigmine, Tacrolimus | [2] Pyridostigmine Pyridostigmine, Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Pyridostigmine bromide
,
Tacrolimus
💬
| [6] ACHE ACHE, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [36] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 1442 | Pyridoxine | [1] Pyridoxine Pyridoxine | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [5] 49 49, 93, 145, 234, 320 💬
|
| 1443 | Pyridoxine 10mg | [1] Pyridoxine Pyridoxine | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 93 93 💬
|
| 1444 | Pyridoxine 10mg BP | [1] Pyridoxine Pyridoxine | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 93 93 💬
|
| 1445 | PYRIDOXINE PHOSPHATE | [2] Pyridoxine Pyridoxine, Pyridoxine phosphate | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 234 234 💬
|
| 1446 | Pyridoxine plus prednisolone | [2] Prednisolone Prednisolone, Pyridoxine | [3] Prednisolone
Prednisolone
,
Pyridoxine hydrochloride
,
Pyridoxine
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 💬
|
| 1447 | PYRIMETHAMINE | [1] Pyrimethamine Pyrimethamine | [1] Pyrimethamine
Pyrimethamine
💬
| - | - | [4] 2 2, 4, 19, 65 💬
|
| 1448 | Pyrophosphate | - | - | - | - | [1] 51 51 💬
|
| 1449 | Pyrrolidine | [1] Pyrrolidine Pyrrolidine | - | - | - | [2] 28 28, 97 💬
|
| 1450 | Pyrrolidone | [1] Pyrrolidone Pyrrolidone | - | - | - | [1] 28 28 💬
|
| 1451 | Pyruvate, creatine, niacinamide | [1] Creatine Creatine | - | - | - | [1] 5 5 💬
|
| 1452 | PyVST | - | - | - | - | [1] 25 25 💬
|